Q2 HOLDINGS, INC., 10-K filed on 2/12/2025
Annual Report
v3.25.0.1
Cover Page - USD ($)
12 Months Ended
Dec. 31, 2024
Jan. 31, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity Registrant Name Q2 Holdings, Inc.    
Entity Incorporation, State or Country Code DE    
Entity File Number 001-36350    
Entity Tax Identification Number 20-2706637    
Entity Address, Address Line One 10355 Pecan Park Boulevard    
Entity Address, City or Town Austin    
Entity Address, State or Province TX    
Entity Address, Postal Zip Code 78729    
City Area Code 833    
Local Phone Number 444-3469    
Title of 12(b) Security Common Stock, $0.0001 par value    
Trading Symbol QTWO    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Smaller Reporting Company false    
Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction Flag false    
Entity Shell Company false    
Entity Public Float     $ 3,622,032,451
Entity Common Stock Shares Outstanding   60,727,986  
Documents Incorporated by Reference
Part III of this Annual Report on Form 10-K incorporates certain information by reference from the definitive proxy statement for the registrant's 2025 Annual Meeting of Stockholders to be filed within 120 days of the registrant's fiscal year ended December 31, 2024, or the Proxy Statement. Except with respect to information specifically incorporated by reference in this Annual Report on Form 10-K, the Proxy Statement is not deemed to be filed as part of this Annual Report on Form 10-K.
   
Entity Central Index Key 0001410384    
Amendment Flag false    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
v3.25.0.1
Audit Information
12 Months Ended
Dec. 31, 2024
Auditor Information [Abstract]  
Auditor Firm ID 42
Auditor Name Ernst & Young LLP
Auditor Location Austin, Texas
v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 358,560 $ 229,655
Restricted cash 2,233 3,977
Investments 88,066 94,353
Accounts receivable, net 42,084 42,899
Contract assets, current portion, net 7,888 9,193
Prepaid expenses and other current assets 23,512 11,625
Deferred solution and other costs, current portion 26,611 27,521
Deferred implementation costs, current portion 9,706 8,741
Total current assets 558,660 427,964
Property and equipment, net 31,528 41,178
Right of use assets 30,402 35,453
Deferred solution and other costs, net of current portion 28,116 26,090
Deferred implementation costs, net of current portion 26,408 21,480
Intangible assets, net 94,633 121,572
Goodwill 512,869 512,869
Contract assets, net of current portion and allowance 9,483 12,210
Other long-term assets 2,696 2,609
Total assets 1,294,795 1,201,425
Current liabilities:    
Accounts payable 9,354 19,353
Accrued liabilities 18,239 16,471
Accrued compensation 32,949 26,580
Convertible notes, current portion 190,331 0
Deferred revenues, current portion 137,700 118,723
Lease liabilities, current portion 10,327 10,436
Total current liabilities 398,900 191,563
Convertible notes, net of current portion 302,115 490,464
Deferred revenues, net of current portion 27,281 17,350
Lease liabilities, net of current portion 38,346 45,588
Other long-term liabilities 10,357 7,981
Total liabilities 776,999 752,946
Commitments and contingencies (Note 11)
Stockholders' equity:    
Preferred stock: $0.0001 par value; 5,000 shares authorized, no shares issued or outstanding as of December 31, 2024 and 2023 0 0
Common stock: $0.0001 par value; 150,000 shares authorized, 60,728 shares issued and outstanding as of December 31, 2024, and 59,031 shares issued and outstanding as of December 31, 2023 6 6
Additional paid-in capital 1,183,893 1,075,278
Accumulated other comprehensive loss (1,873) (1,111)
Accumulated deficit (664,230) (625,694)
Total stockholders' equity 517,796 448,479
Total liabilities and stockholders' equity $ 1,294,795 $ 1,201,425
v3.25.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value (in usd per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 150,000,000 150,000,000
Common stock, shares issued (in shares) 60,728,000 59,031,000
Common stock, shares outstanding (in shares) 60,728,000 59,031,000
v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenues $ 696,464 $ 624,624 $ 565,673
Cost of revenues 341,983 321,973 309,328
Gross profit 354,481 302,651 256,345
Operating expenses:      
Sales and marketing 105,951 109,522 108,214
Research and development 143,244 137,334 130,103
General and administrative 122,942 110,186 90,163
Transaction-related costs 0 24 1,176
Amortization of acquired intangibles 16,979 20,667 18,248
Lease and other restructuring charges 7,628 10,975 13,202
Total operating expenses 396,744 388,708 361,106
Loss from operations (42,263) (86,057) (104,761)
Other income (expense):      
Interest and other income 16,342 10,098 5,362
Interest and other expense (4,939) (5,732) (6,676)
Gain on extinguishment of debt 0 19,869 0
Total other income (expense), net 11,403 24,235 (1,314)
Loss before income taxes (30,860) (61,822) (106,075)
Provision for income taxes (7,676) (3,562) (2,908)
Net loss (38,536) (65,384) (108,983)
Other comprehensive income (loss):      
Unrealized gain (loss) on available-for-sale investments 392 1,800 (1,873)
Foreign currency translation adjustment (1,154) 61 (964)
Comprehensive loss $ (39,298) $ (63,523) $ (111,820)
Net loss per common share, basic (in usd per share) $ (0.64) $ (1.12) $ (1.90)
Net loss per common share, diluted (in usd per share) $ (0.64) $ (1.12) $ (1.90)
Weighted average common shares outstanding:      
Basic (in shares) 60,105 58,354 57,300
Diluted (in shares) 60,105 58,354 57,300
v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock and additional paid-in capital
Common stock and additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Common stock
Beginning balance at Dec. 31, 2021 $ 570,296 $ 1,064,364 $ (156,979) $ (493,933) $ 42,606 $ (135)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense   69,039          
Exercise of stock options   707          
Issuance of common stock under ESPP   5,175          
Settlement of capped calls   0          
Net loss (108,983)     (108,983)      
Other comprehensive income (loss)           (2,837)  
Ending balance at Dec. 31, 2022 $ 419,024 982,306 0 (560,310) 0 (2,972)  
Common stock, beginning balance (in shares) at Dec. 31, 2021             56,928
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)             27
Issuance of common stock under ESPP (in shares)             171
Shares issued for the vesting of restricted stock awards (in shares)             609
Common stock, ending balance (in shares) at Dec. 31, 2022             57,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting standards update [Extensible List] Accounting Standards Update 2020-06 [Member]            
Stock-based compensation expense   84,442          
Exercise of stock options   2,297          
Issuance of common stock under ESPP   6,100          
Settlement of capped calls   139          
Net loss $ (65,384)     (65,384)      
Other comprehensive income (loss)           1,861  
Ending balance at Dec. 31, 2023 $ 448,479 1,075,284 $ 0 (625,694) $ 0 (1,111)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)             74
Issuance of common stock under ESPP (in shares)             255
Shares issued for the vesting of restricted stock awards (in shares)             967
Common stock, ending balance (in shares) at Dec. 31, 2023 59,031           59,031
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation expense   94,356          
Exercise of stock options   8,404          
Issuance of common stock under ESPP   5,855          
Settlement of capped calls   0          
Net loss $ (38,536)     (38,536)      
Other comprehensive income (loss)           (762)  
Ending balance at Dec. 31, 2024 $ 517,796 $ 1,183,899   $ (664,230)   $ (1,873)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares)             234
Issuance of common stock under ESPP (in shares)             150
Shares issued for the vesting of restricted stock awards (in shares)             1,313
Common stock, ending balance (in shares) at Dec. 31, 2024 60,728           60,728
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (38,536) $ (65,384) $ (108,983)
Adjustments to reconcile net loss to net cash from operating activities:      
Amortization of deferred implementation, solution and other costs 27,038 25,848 23,270
Depreciation and amortization 68,809 71,707 61,659
Amortization of debt issuance costs 2,059 2,104 2,719
Amortization of premiums and discounts on investments (1,273) (3,192) (302)
Stock-based compensation expense 89,215 79,188 65,157
Deferred income taxes 2,106 636 1,611
Gain on extinguishment of debt 0 (19,312) 0
Lease impairments 1,669 4,075 11,669
Other non-cash items (490) 311 250
Changes in operating assets and liabilities:      
Accounts receivable, net 906 4,090 286
Prepaid expenses and other current assets (12,000) (787) 494
Deferred solution and other costs (14,202) (17,412) (7,599)
Deferred implementation costs (17,663) (14,954) (12,243)
Contract assets, net 4,030 3,693 (1,101)
Other long-term assets 7,282 5,576 7,312
Accounts payable (9,788) 9,353 (548)
Accrued liabilities 5,968 (492) (9,845)
Deferred revenues 28,918 (3,092) 10,212
Deferred rent and other long-term liabilities (8,297) (11,664) (7,462)
Net cash provided by operating activities 135,751 70,292 36,556
Cash flows from investing activities:      
Purchases of investments (95,788) (76,865) (292,984)
Maturities of investments 103,739 220,776 162,521
Purchases of property and equipment (6,692) (5,673) (11,142)
Capitalized software development costs (22,339) (24,970) (18,910)
Business combinations, net of cash acquired 0 0 (5,040)
Net cash provided by (used in) investing activities (21,080) 113,268 (165,555)
Cash flows from financing activities:      
Payment for maturity of 2023 convertible notes 0 (10,908) 0
Payment for repurchases of convertible notes 0 (149,640) 0
Proceeds from capped calls related to convertible notes 0 139 0
Debt issuance costs related to revolving credit agreement (942) 0 0
Proceeds from exercise of stock options and ESPP 14,259 8,397 5,882
Net cash provided by (used in) financing activities 13,317 (152,012) 5,882
Effect of exchange rate changes on cash, cash equivalents and restricted cash (827) 182 (802)
Net increase (decrease) in cash, cash equivalents and restricted cash 127,161 31,730 (123,919)
Cash, cash equivalents and restricted cash, beginning of period 233,632 201,902 325,821
Cash, cash equivalents and restricted cash, end of period 360,793 233,632 201,902
Supplemental disclosures of cash flow information:      
Cash paid for taxes, net of refund 5,880 2,622 875
Cash paid for interest 2,680 2,651 2,891
Supplemental disclosure of non-cash investing and financing activities:      
Stock-based compensation for capitalized software development 2,882 3,149 2,396
Capitalized software development costs included in accounts payable and accrued liabilities 0 0 492
Property and equipment acquired and included in accounts payable and accrued liabilities 341 478 353
Property and equipment acquired through tenant improvement allowance $ 615 $ 0 $ 0
v3.25.0.1
Organization and Description of Business
12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Description of Business Organization and Description of Business
Q2 Holdings, Inc. and its wholly-owned subsidiaries, collectively the Company, is a leading provider of digital solutions to financial institutions, financial technology companies, or FinTechs, and alternative finance companies, or Alt-FIs, wishing to incorporate banking into their customer engagement and servicing strategies. The Company's solutions transform the ways in which its customers engage with account holders and end users, or End Users, enabling them to deliver robust suites of digital banking, digital lending and relationship pricing, and banking-as-a-service, or BaaS, services that make it possible for account holders and End Users to transact and engage anytime, anywhere and on any device. The Company delivers its solutions to the substantial majority of its customers using a software-as-a-service, or SaaS, model under which its customers pay subscription fees for the use of the Company's solutions. The Company was incorporated in Delaware in March 2005 and is a holding company that owns 100% of the outstanding capital stock of Q2 Software, Inc. The Company's headquarters are located in Austin, Texas.
v3.25.0.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP, and Securities and Exchange Commission, or SEC, requirements. The consolidated financial statements include the accounts of Q2 Holdings, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses. Significant items subject to such estimates include: revenue recognition; estimate of credit losses; fair value of certain stock awards issued; the carrying value of goodwill; the fair value of acquired intangibles; the useful lives of property and equipment and long-lived intangible assets; the impairment assessment of long-lived assets; and, income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all highly liquid investments acquired with an original maturity of ninety days or less at the date of purchase to be cash equivalents. Cash equivalents are stated at cost or fair value based on the underlying security.
Restricted Cash
Restricted cash consists of deposits held as collateral for the Company's secured letters of credit or bank guarantees issued in place of security deposits for the Company's corporate headquarters and various other leases, deposits held by the Company on behalf of its medical insurance carrier reserved for the use of claim payments and deposits that are restricted to withdrawal or use as of the reporting date under the contractual terms of certain customer arrangements.
Investments
Investments typically include U.S. government securities, corporate bonds, commercial paper, certificates of deposit, money market funds and other equity investments. All debt investments are considered available for sale and are carried at fair value. Equity investments without a readily determinable fair value, where the Company has no influence over the operating and financial policies of the investee, are recorded at cost, less impairment and adjusted for subsequent observable price changes obtained from orderly transactions for identical or similar investments issued by the same investee. Adjustments resulting from impairment, fair value or observable price changes are accounted for in the consolidated statements of comprehensive loss.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, restricted cash, investments, accounts receivable and contract assets. The Company's cash and cash equivalents, restricted cash and investments are placed with high credit quality financial institutions and issuers, and at times may exceed federally insured limits. The Company has not experienced any loss relating to cash and cash equivalents or restricted cash in these accounts. The Company provides credit, in the normal course of business, to a majority of its customers. The Company performs periodic credit evaluations of its customers' financial condition and generally does not require collateral. No individual customer accounted for 10% or more of revenues for each of the years ended December 31, 2024, 2023 and 2022. No individual customer accounted for 10% or more of accounts receivable, net, as of December 31, 2024 and December 31, 2023.
Contract Assets and Deferred Revenue
The timing of revenue recognition, billings and cash collections can result in billed accounts receivable, unbilled receivables, contract assets, and deferred revenues or contract liabilities. Billings scheduled to occur after the performance obligation has been satisfied and revenue recognition has occurred result in contract assets. Contract assets that are expected to be billed during the succeeding twelve-month period are recorded in contract assets, current portion, and the remaining portion is recorded in contract assets, net of current portion on the consolidated balance sheets at the end of each reporting period.
Contract liabilities, or deferred revenues, primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments or deposits received from customers in advance for implementation, maintenance and other services, as well as subscription fees. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed. The Company recognizes deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Contract liabilities that are expected to be recognized as revenues during the succeeding twelve-month period are recorded in deferred revenues, current portion, and the remaining portion is recorded in deferred revenues, net of current portion, on the consolidated balance sheets at the end of each reporting period.
The Company's payment terms vary by the type and location of its customer and the products or services offered. The period of time between invoicing and when payment is due is not significant. For certain products or services and customer types, the Company requires payment before the products or services are delivered to the customer.
Accounts Receivable
Accounts receivable are stated at net realizable value, including both billed and unbilled receivables to customers. Unbilled receivable balances arise primarily when the Company provides services in advance of billing for those services. Generally, billing for revenues related to the number of End Users and the number of transactions processed by the customers' End Users that are included in the customers' minimum subscription fee occurs in the month the revenue is recognized, resulting in accounts receivable. Billing for revenues relating to the number of End Users and the number of transactions processed by the End Users that are in excess of the customers' minimum subscription fees are, generally, billed in the month following the month the revenues were earned, resulting in an unbilled receivable. Unbilled receivables of $7.7 million and $7.4 million were included in the accounts receivable balance as of December 31, 2024 and 2023, respectively.
Deferred Implementation Costs
The Company capitalizes certain personnel and other costs, such as employee salaries, stock-based compensation, benefits and the associated payroll taxes that are identifiable and directly related to the implementation of its solutions. The Company analyzes implementation costs that may be capitalized to assess their recoverability and only capitalizes costs that it anticipates being recoverable through the terms of the associated contract. The Company begins amortizing the deferred implementation costs for an implementation to cost of revenues once the revenue recognition criteria have been met, and the Company amortizes those deferred implementation costs ratably over the expected period of customer benefit. The Company has determined this period to be the estimated life of the technology for new contracts, which is estimated to be five to seven years, or over the term of the agreement for contract renewals and customer expansions. The Company determined the period of benefit by considering factors such as historically high renewal rates with similar customers and contracts, initial contract length, an expectation that there will still be a demand for the product at the end of its term and the significant costs to switch to a competitor's product, all of which are governed by the estimated useful life of the technology. The Company monitors
deferred implementation costs for impairment and records impairment when customers terminate or allow services to lapse due to contract modifications and/or from other assessments as needed. Any impairment losses identified are recognized in the form of an expense acceleration with the applicable amount recorded to deferred implementation costs, current portion and/or deferred implementation costs, net of current portion on the consolidated balance sheet and in cost of revenues in the consolidated statements of comprehensive loss.
The portion of deferred implementation costs expected to be amortized during the succeeding twelve-month period is recorded in current assets as deferred implementation costs, current portion, and the remainder is recorded in long-term assets as deferred implementation costs, net of current portion on the consolidated balance sheets. The Company recognized $14.0 million, $13.4 million and $11.5 million of amortization during the years ended December 31, 2024, 2023 and 2022, respectively. Amortization expense is included in cost of revenues in the consolidated statements of comprehensive loss.
Deferred Solution and Other Costs
The Company capitalizes sales commissions and other third-party costs such as third-party licenses and maintenance related to its customer agreements. The Company capitalizes sales commissions because the commission payments are considered incremental and recoverable costs of obtaining a contract with a customer. The Company capitalizes commissions and related bonuses for those involved in the sale which are incremental to the sale and their associated management. Substantially all commissions are paid in a single payment once the contract has been executed. The Company begins amortizing deferred solution and other costs for a particular customer agreement once the revenue recognition criteria are met and amortizes those deferred costs over the expected period of customer benefit. The Company has determined this period to be the estimated life of the technology for new contracts, which is estimated to be five to seven years, or over the term of the agreement for contract renewals and customer expansions. The Company determined the period of benefit by considering factors such as historically high renewal rates with similar customers and contracts, initial contract length, an expectation that there will still be a demand for the product at the end of its term and the significant costs to switch to a competitor's product, all of which are governed by the estimated useful life of the technology. The Company monitors deferred solution and other costs for impairment and records impairment when customers terminate or allow services to lapse due to contract modifications and/or from other assessments as needed. Any impairment losses identified are recognized in the form of an expense acceleration with the applicable amount recorded to deferred solution and other costs, current portion and/or deferred solution and other costs, net of current portion on the consolidated balance sheet and in sales and marketing expenses in the consolidated statements of comprehensive loss.
The Company capitalizes solution and other costs that it anticipates being recoverable. The portion of capitalized costs expected to be amortized during the succeeding twelve-month period is recorded in current assets as deferred solution and other costs, current portion, and the remainder is recorded in long-term assets as deferred solution and other costs, net of current portion. The Company recognized $13.0 million, $12.5 million and $11.7 million of amortization from sales commissions during the years ended December 31, 2024, 2023 and 2022 respectively. Amortization expense related to sales commissions is included in sales and marketing expenses in the consolidated statements of comprehensive loss.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful lives of the related assets. Maintenance and repairs that do not extend the life of or improve an asset are expensed in the period incurred.
The estimated useful lives of property and equipment are as follows:
Computer hardware and equipment
3 - 5 years
Purchased software and licenses
3 - 5 years
Furniture and fixtures
7 years
Leasehold improvementsLesser of estimated useful life or lease term
Purchase Price Allocation, Intangible Assets, and Goodwill
The purchase price allocation for business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed based on their respective fair values. The Company determines whether substantially all the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the single asset or group of assets, as applicable, is not a business. If it is not met, the Company determines whether the single asset or group of assets, as applicable, meets the definition of a business.
In connection with its business combinations, the Company recorded certain intangible assets, including acquired technology, customer relationships, trademarks, and non-compete agreements. Amounts allocated to the acquired intangible assets are amortized on a straight-line basis over the estimated useful lives. The Company periodically reviews the estimated useful lives and fair values of its identifiable intangible assets, taking into consideration any events or circumstances which might result in a diminished fair value or revised useful life.
The excess purchase price over the fair value of assets acquired is recorded as goodwill. The Company tests goodwill for impairment annually in October, or whenever events or changes in circumstances indicate an impairment may have occurred. Because the Company operates as a single reporting unit, the impairment test is performed at the consolidated entity level by comparing the estimated fair value of the Company to the carrying value of the Company. The Company estimates the fair value of the reporting unit using a "step one" analysis using a fair-value-based approach based on market capitalization to determine if it is more likely than not that the fair value of the reporting unit is less than its carrying amount. Determining the fair value of goodwill is subjective in nature and often involves the use of estimates and assumptions including, without limitation, use of estimates of future prices and volumes for the Company's products, capital needs, economic trends and other factors which are inherently difficult to forecast. If actual results, or the plans and estimates used in future impairment analyses are lower than the original estimates used to assess the recoverability of these assets, the Company could incur impairment charges in a future period.
Revenues
Revenues are recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services over the term of the agreement, generally when the Company's solutions are implemented and made available to its customers. The promised consideration may include fixed amounts, variable amounts or both. Revenues are recognized net of sales credits and allowances.

Revenue-generating activities are directly related to the sale, implementation and support of the Company's solutions within a single operating segment. The Company derives the majority of its revenues from subscription fees for the use of its solutions hosted in either the Company's third-party data centers or with third-party public cloud service providers, transactional revenue from bill-pay solutions and remote deposit products, revenues for professional services and implementation services related to its solutions and certain third-party related pass-through fees.
Subscription Revenues
The Company's software solutions are available for use as hosted application arrangements under subscription fee agreements without licensing rights to the software. Subscription fees from these applications, including contractual periodic price increases, are recognized over time on a ratable basis over the customer agreement term beginning on the date the Company's solution is made available to the customer. Amounts that have been invoiced are recorded in accounts receivable and deferred revenues or revenues, depending on whether the revenue recognition criteria have been met. Periodic price increases are estimated at contract inception where appropriate and result in contract assets as revenue recognition may exceed the amount billed early in the contract. Additional fees for monthly usage above the levels included in the standard subscription fee are recognized as revenue in the month when the usage amounts are determined and reported.
A small portion of the Company's customers host and manage the Company's solutions on-premises or in third-party data centers under term license and maintenance agreements. Term licenses sold with maintenance entitle the customer to technical support, upgrades and updates to the software on a when-and-if-available basis. For these customers, the Company recognizes software license revenue once the customer obtains control of the license, which generally occurs at the start of each license term and recognizes the remaining arrangement consideration for maintenance revenue over time on a ratable basis over the term of the software license. Revenues from term licenses and maintenance agreements were not significant in the periods presented.
Transactional Revenues
The Company generates a majority of its transactional revenues based on the number of bill-pay transactions that End Users initiate on its digital banking platform. The Company also generates a portion of its transactional revenues from third-party fees related to End Users utilizing remote deposit products and from fees generated when End Users utilize debit cards integrated with its Helix products. The Company recognizes revenue for transaction services in the month incurred based on actual or estimated transactions.
Services and Other Revenues
Implementation services are required for new digital solutions and other standalone contracts, and there is a significant level of integration and configuration for each customer. The Company's revenue for implementation services is billed upfront and generally recognized over time on a ratable basis over the customer's term for its hosted application agreements. Implementation services for on-premises agreements are recognized at commencement date. Under certain circumstances, the Company has determined that these implementation services qualify as a separate performance obligation in certain markets and geographies, and the implementation services for these agreements are recognized over time as services are performed.

Professional services revenues consist primarily of Integrated Services. Integrated Services revenue is generated from select established customer relationships where the Company has engaged with the customer for more tailored, premium professional services, resulting in a deeper and ongoing level of engagement with them. Professional services revenues also consist of custom services, core conversion services and other general professional services. These revenues are generally billed and recognized when delivered. Other Revenues also include certain third-party related pass-through fees primarily in its Helix business that are not transactional in nature.

Certain out-of-pocket expenses billed to customers are recorded as revenues rather than an offset to the related expense.
Significant Judgments
Performance Obligations and Standalone Selling Price
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of accounting. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. The Company has contracts with customers that often include multiple performance obligations, usually including multiple subscription and implementation services. For these contracts, the Company accounts for individual performance obligations that are separately identifiable by allocating the contract's total transaction price to each performance obligation in an amount based on the relative standalone selling price, or SSP, of each distinct good or service in the contract. In determining whether implementation services are distinct from subscription services, the Company considers various factors including the significant level of integration, interdependency, and interrelation between the implementation and subscription service, as well as the inability of the customer's personnel or other service providers to perform significant portions of the services. The Company has concluded that the implementation services included in contracts with multiple performance obligations across the majority of its markets and product offerings are not distinct and, as a result, the Company defers any arrangement fees for implementation services and recognizes such amounts over time on a ratable basis as one performance obligation with the underlying subscription revenue for the initial agreement term of the hosted application agreements. The Company has concluded that for some of its products in certain markets the implementation services included in contracts with multiple performance obligations are distinct and, as a result, the Company recognizes implementation fees on such arrangements over time as services are performed.
The majority of the Company's revenue recognized at a particular point in time is for usage revenue, on-premise software licenses and certain professional services. These services are recognized as the customer obtains control of the asset, as services are performed, or the point the customer obtains control of the software.

Judgment is required to determine the SSP for each distinct performance obligation. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The Company determines SSP based on overall pricing objectives and strategies, taking into consideration entity-specific factors, including the value of its contracts, historical standalone sales, customer demographics and the numbers and types of users within its contracts.
Variable Consideration
The Company recognizes usage revenue related to End Users accessing its products in excess of contracted amounts and from fees that End Users generate using the Company's solutions. Judgment is required to determine the accounting for these types of revenue. The Company considers various factors including the degree to which usage is interdependent or interrelated to past services and contractual price per user and their relationship to market terms. The Company has concluded that its usage revenue relates specifically to the transfer of the service to the customer and is consistent with the allocation objective of Topic 606 when considering all of the performance obligations and payment terms in the contract. Therefore, the Company recognizes usage revenue on a monthly or quarterly basis in accordance with the agreement, as determined and reported. This allocation reflects the amount the Company expects to receive for the services for the given period.

The Company sometimes provides credits or incentives to its customers. Known and estimable credits and incentives represent a form of variable consideration, which are estimated at contract inception and generally result in reductions to revenues recognized for a particular contract. These estimates are updated at the end of each reporting period as additional information becomes available. The Company believes that there will not be significant changes to its estimates of variable consideration as of December 31, 2024.
Other Considerations
The Company evaluates whether it is the principal (i.e., reports revenues on a gross basis) or agent (i.e., reports revenues on a net basis) with respect to the vendor reseller agreements pursuant to which the Company resells certain third-party solutions along with its solutions. Generally, the Company reports revenues from these types of contracts on a gross basis, meaning the amounts billed to customers are recorded as revenues, and expenses incurred are recorded as cost of revenues. Where the Company is the principal, it first obtains control of the inputs to the specific good or service and directs their use to create the combined output. The Company's control is evidenced by its involvement in the integration of the good or service on its platform before it is transferred to its customers and is further supported by the Company being primarily responsible to its customers and having a level of discretion in establishing pricing. Revenues provided from agreements in which the Company is an agent are insignificant.
Cost of Revenues
Cost of revenues is comprised primarily of salaries and other personnel-related costs, including employee benefits, bonuses and stock-based compensation, for employees providing services to the Company's customers. This includes the costs of the Company's personnel performing implementation, customer support, third-party data center and customer training activities. Cost of revenues also includes the direct costs of bill-pay and other third-party intellectual property included in the Company's solutions, the amortization of deferred solution and services costs, amortization of certain software development costs, co-location facility costs and depreciation of the Company's data center assets, debit card related pass-through fees, third-party public cloud service providers, an allocation of general overhead costs, the amortization of acquired technology intangibles and referral fees. The Company allocates general overhead expenses to all departments based on the number of employees in each department, which the Company considers to be a fair and representative means of allocation.
The Company capitalizes certain personnel costs directly related to the implementation of its solutions to the extent those costs are recoverable from future revenues. The Company amortizes the costs for an implementation once revenue recognition commences, and the Company amortizes those implementation costs to cost of revenues over the expected period of customer benefit, which has been determined to be the estimated life of the technology. Other costs not directly recoverable from future revenues are expensed in the period incurred. The Company also amortizes the costs capitalized for software development, as described in the next section, to cost of revenues, when products and enhancements are released or made available over the products' estimated economic lives.
Software Development Costs
During the application development stage, the Company capitalizes certain development costs associated with internal use software and the Company's SaaS platform. Software development costs include salaries and other personnel-related costs for those employees who are directly associated with and who devote time to developing the Company's software solutions, including employee benefits, stock-based compensation and bonuses attributed to software engineers, quality control teams and third-party development costs. Capitalized software development costs are computed on an individual product basis. The Company also capitalizes certain costs related to specific enhancements when it is probable the expenditures will result in additional features and functionality. Capitalization ceases for products and enhancements when released or made available. Software development costs for internal-use software are amortized to cost of revenues when products and enhancements are released or made available over the products' estimated economic lives, which are expected to be five years. The costs related to software development are included in intangible assets, net on the consolidated balance sheets. Costs incurred in the preliminary stages of development and maintenance costs are expensed as incurred.
Research and Development Costs
Research and development expenses include salaries and personnel-related costs, including employee benefits, bonuses and stock-based compensation, third-party contractor expenses, software development costs, allocated overhead and other related expenses incurred in developing new solutions and enhancing existing solutions.
Certain research and development costs that are related to the Company's software development, which include salaries and other personnel-related costs, comprised of employee benefits, stock-based compensation and bonuses attributed to programmers, software engineers and quality control teams working on the Company's software solutions, are capitalized and included in intangible assets, net on the consolidated balance sheets.
Advertising
Advertising costs of the Company are generally expensed the first time the advertising takes place. Advertising costs were $4.3 million, $4.3 million and $4.4 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company entered into a long-term stadium sponsorship agreement in 2020, and beginning in the second quarter of 2021, payments under this arrangement are deferred and expensed as advertising costs on a straight-line basis over the term of the arrangement.
Sales Tax
The Company presents sales taxes and other taxes collected from customers and remitted to governmental authorities on a net basis and, as such, excludes them from revenues.
Comprehensive Loss
Comprehensive loss includes net loss as well as other changes in stockholders' equity that result from transactions and economic events other than those with stockholders. Other comprehensive loss consists of net loss, unrealized gains and losses on available-for-sale investments, and foreign currency translation adjustments.
Stock-Based Compensation
Stock-based compensation consists of restricted stock units, or RSUs, performance-based restricted stock units, and purchase rights under our employee stock purchase plan, or ESPP, and is used to compensate employees, directors and consultants. All awards are measured at fair value on grant date and forfeitures are recognized as they occur.
The Company values RSUs at the closing market price on the date of grant. RSUs typically vest in equal installments over a four-year period and compensation expense is recognized straight-line over the requisite service period.
The Company values purchase rights under the ESPP using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires inputs including the risk-free interest rate, expected term and expected volatility and the Company assumes no dividend yield. The Company's ESPP has two six-month offering periods which commence on each June 1 and December 1. The Company recognizes compensation expense straight-line over the withholding period for the ESPP.
The Company grants performance-based restricted stock units which provide for shares of common stock to be earned based on its total stockholder return, or TSR, performance relative to the TSR performance of specified stock indexes, or TSR PSUs, and previously referred to as Market Stock Units, or MSUs. The Company values TSR PSUs and MSUs on grant date using the Monte Carlo simulation model. The determination of fair value is affected by the Company's stock price and a number of assumptions including the expected volatility and the risk-free interest rate. The Company's expected volatility at the date of grant is based on the historical volatilities of its stock and peer firms' stocks and the Index over the performance period. The Company assumes no dividend yield and recognizes compensation expense ratably over the performance period of the award, as applicable. The number of TSR PSUs and MSUs that vest is based on actual TSR relative to the TSR benchmark as set forth in the award agreement. The minimum percentage that can vest is 0%, with a maximum percentage of 200%. TSR PSUs and MSUs will vest over two-year and three-year performance periods. The Company recognizes compensation expense using the graded attribution method on a straight-line basis over the performance period for each award, as applicable.
The Company also grants performance-based restricted stock units which provide for shares of common stock to be earned based on its attainment of Adjusted EBITDA as a percentage of non-GAAP Revenue relative to a target specified in the applicable agreement, or EBITDA PSUs. The Company values EBITDA PSUs at the closing market price on the date of grant. The minimum percentage of EBITDA PSUs that can vest is 0%, with a maximum percentage of 200%. The vesting of EBITDA PSUs is conditioned upon the achievement of certain internal targets and will vest over a two-year and three-year performance period. The Company recognizes compensation expense using the accelerated attribution method over the performance period, if it is probable that the performance condition will be achieved. Adjustments to compensation expense are made each reporting period based on changes in our estimate of the number of EBITDA PSUs that are probable of vesting.
Convertible Senior Notes
The Company accounts for its convertible notes as a liability at face value less unamortized debt issuance costs. Debt issuance costs are amortized to interest expense over the respective term of its convertible notes on a straight-line basis, which approximates the effective interest method.
Leases
The Company determines if a contract contains a lease for accounting purposes at the inception of the arrangement. The Company has elected to apply the practical expedient which allows the Company to account for lease and non-lease components of a contract as a single leasing arrangement. In addition, the Company has elected the practical expedients related to lease classification and the short-term lease exemption, whereby leases with initial terms of one year or less are not capitalized and instead expensed generally on a straight-line basis over the lease term. The Company is primarily a lessee with a lease portfolio comprised mainly of real estate and equipment leases. As of December 31, 2024, the Company had no finance leases.
Operating lease assets are included on the Company's consolidated balance sheets in non-current assets as a right of use asset and represent the Company's right to use an underlying asset for the lease term. Operating lease liabilities are included on the Company's consolidated balance sheets in lease liabilities, current portion, for the portion that is due within 12 months and in lease liabilities, net of current portion, for the portion that is due beyond 12 months of the financial statement date and represent the Company's obligation to make lease payments.
Right of use assets and lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term using an appropriate discount rate. If an implicit rate is not readily determined by the Company's leases, the Company utilizes the incremental borrowing rate based on the available information at the commencement date to determine the present value of lease payments. The depreciable lives of the underlying leased assets are generally limited to the expected lease term inclusive of any optional lease renewals where the Company concludes at the inception of the lease that the Company is reasonably certain of exercising those options. The right of use asset calculation may
also include any initial direct costs paid and is reduced by any lease incentives provided by the lessor. Lease expense for lease payments is recognized on a straight-line basis over the lease term, except for impaired leases for which the lease expense is recognized on a declining basis over the remaining lease term.
Impairment of Long-Lived Assets
Impairment of long-lived assets such as property and equipment, acquired intangible assets, capitalized software development costs and right of use assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The Company evaluates the recoverability of its long-lived assets by comparing the carrying amount of the asset group to the estimated undiscounted future cash flows. If the carrying value is not recoverable, an impairment is recognized to the extent that the carrying value of the asset group exceeds its fair value.
Income Taxes
Deferred income taxes are provided for the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their respective tax bases and operating loss carryforwards and credits using enacted tax rates expected to be in effect in the years in which the differences are expected to reverse. The Company assesses the likelihood that deferred tax assets will be realized and recognizes a valuation allowance if it is more likely than not that some portion of the deferred tax assets will not be realized. This assessment requires judgment as to the likelihood and amounts of future taxable income by tax jurisdiction. To date, the Company has provided a valuation allowance against most of its deferred tax assets as it believes the objective and verifiable evidence of its historical pretax net losses outweighs any positive evidence of its forecasted future results. The Company will continue to monitor the positive and negative evidence, and it will adjust the valuation allowance as sufficient objective positive evidence becomes available.
The Company evaluates its uncertain tax positions based on a determination of whether and how much of a tax benefit or expense taken by the Company in its tax filings or positions is more likely than not to be realized. The Company believes it has accrued adequate reserves related to its uncertain tax positions; however, ultimate determination of the Company's liability is subject to audit by taxing authorities in the ordinary course of business. The Company records interest and penalties associated with any uncertain tax positions as a component of income tax expense.
Basic and Diluted Net Loss per Common Share
The following table sets forth the computations of net loss per share for the periods listed:
Year ended December 31,
 202420232022
Numerator: 
Net loss $(38,536)$(65,384)$(108,983)
Denominator: 
Weighted-average common shares outstanding, basic and diluted60,105 58,354 57,300 
Net loss per common share, basic and diluted$(0.64)$(1.12)$(1.90)
Due to net losses for each of the years ended December 31, 2024, 2023 and 2022, basic and diluted loss per share were the same, as the effect of all potentially dilutive securities would have been anti-dilutive. The following table sets forth the anti-dilutive common share equivalents for the periods listed:
 Year ended December 31,
 202420232022
Stock options, restricted stock units, market stock units and performance stock units4,590 4,776 3,667 
Shares issuable pursuant to the ESPP68 102 85 
Shares related to convertible notes4,793 5,042 6,256 
9,451 9,920 10,008 
Recent Accounting Pronouncements
In November 2023, the Financial Accounting Standard Board, or FASB, issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which amends the disclosure to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an annual and interim basis to better understand the reporting entity's performance and prospects for future net cash flows and make more informed judgments. All public entities are required to report segment information in accordance with the new guidance starting in annual periods beginning after December 15, 2023. The Company adopted the standard during the year ended December 31, 2024. See Note 16 - Segments and Geographic Information for further detail.
In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvement to Income Tax Disclosures" which requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The ASU is effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its financial statement disclosures.
In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses" which requires public companies to disclose additional information about certain costs and expenses in the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027, on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its financial statement disclosures.
v3.25.0.1
Revenue
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregation of Revenue
The following table disaggregates the Company's revenue by major source:
 Year Ended December 31,
 202420232022
Subscription$553,610 $475,945 $412,040 
Transactional68,489 65,416 67,373 
Services and Other74,365 83,263 86,260 
Total Revenues$696,464 $624,624 $565,673 
Deferred Revenues
The increase in the deferred revenue balance for the year ended December 31, 2024 is primarily driven by the amounts due in advance of satisfying the Company's performance obligations of $724.1 million for current year invoices and $1.3 million from the netting of contract assets and liabilities on a contract-by-contract basis, partially offset by the recognition of $577.8 million of revenue recognized from current year invoices and the recognition of $118.7 million of revenue that was included in the deferred revenue balance as of December 31, 2023. Amounts recognized from deferred revenues represent primarily revenue from the sale of subscription and implementation services.
Remaining Performance Obligations
On December 31, 2024, the Company had $2.22 billion of remaining performance obligations, which represents contracted revenue minimums that have not yet been recognized, including amounts that will be invoiced and recognized as revenue in future periods. The Company expects to recognize approximately 52% of its remaining performance obligations as revenue in the next 24 months, an additional 34% in the next 25 to 48 months, and the balance thereafter.
Allowance for Credit Losses and Other Reserved Balances
The Company is exposed to credit losses primarily through sales of products and services. The Company assesses the collectability of outstanding contract assets on an ongoing basis and maintains a reserve which is included in the allowance for credit losses for contract assets deemed uncollectible. The Company analyzes the contract asset portfolio for significant risks by considering historical collection experience and forecasting of future collectability to determine the amount of revenues that will ultimately be collected from its customers. Customer type (whether a customer is a financial institution or other digital solution provider) has been identified as the primary specific risk affecting the Company's contract assets, and the estimate for losses is analyzed quarterly and adjusted as necessary. Future collectability may be impacted by current and anticipated economic conditions that could impact the Company's customers. Additionally, specific allowance amounts may be established to record the appropriate provision for customers that have a higher probability of default. The Company has provisioned zero in expected losses for each of the years ended December 31, 2024 and 2023, and no charges were taken against the allowance at either December 31, 2024 or 2023. During each of the years ended December 31, 2024 and 2023, the Company decreased the allowance by less than $0.1 million, primarily as a result of the reduction in total contract asset balances. The allowance for credit losses related to contract assets was $0.02 million and $0.03 million as of December 31, 2024 and 2023, respectively.
The Company assesses the collectability of outstanding accounts receivable on an ongoing basis and maintains an allowance for credit losses for accounts receivable deemed uncollectible. The Company analyzes the accounts receivable portfolio for significant risks and considers prior periods and forecasts future collectability to determine the amount of revenues that will ultimately be collected from its customers. This estimate is analyzed quarterly and adjusted as necessary. Identified risks pertaining to the Company's accounts receivable include the delinquency level and customer type. Future collectability may be impacted by current and anticipated economic conditions that could impact the Company's customers. Due to the short-term nature of such receivables, the estimate of the amount of accounts receivable that may not be collected is based on aging of the accounts receivable balances and the financial condition of customers. Historically, the Company's collection experience has not varied significantly, and bad debt expenses have been insignificant. The Company has provisioned zero and $0.1 million for expected losses for the years ended December 31, 2024 and 2023, respectively, of which $0.1 million and $0.3 million has been written off and charged against the allowance at December 31, 2024 and 2023, respectively. During the twelve months ended December 31, 2024, the Company decreased the allowance by less than $0.05 million. The allowance for credit losses related to accounts receivable was $0.3 million and $0.5 million for the years ended December 31, 2024 and 2023, respectively.
The Company maintains reserves for estimated sales credits issued to customers for billing disputes or other service-related reasons. These allowances are recorded as a reduction against current period revenues and accounts receivable. In estimating this allowance, the Company analyzes prior periods to determine the amounts of sales credits issued to customers compared to the revenues in the period that related to the original customer invoice. This estimate is analyzed semi-annually and adjusted as necessary. The Company also maintains specific reserves for anticipated contract concessions. The allowance for sales credits and specific reserves was $1.0 million and $0.9 million as of December 31, 2024 and 2023, respectively.
The following table shows the Company's allowance for sales credits, credit losses, and other reserved balances as follows:
Beginning BalanceAdditionsDeductionsEnding Balance
Year Ended December 31, 2022$2,761 $2,931 $(3,692)$2,000 
Year Ended December 31, 20232,000 1,214 (1,813)1,401 
Year Ended December 31, 2024$1,401 $1,196 $(1,254)$1,343 
v3.25.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The carrying values of the Company's financial assets not measured at fair value on a recurring basis, principally accounts receivable, restricted cash and accounts payable, approximated their fair values due to the short period of time to maturity or repayment.
Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The current accounting guidance for fair value measurements defines a three-level valuation hierarchy for disclosures as follows:
Level I—Unadjusted quoted prices in active markets for identical assets or liabilities;
Level II—Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and
Level III—Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own assumptions.
The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
The following table details the fair value hierarchy of the Company's financial assets measured at fair value on a recurring basis as of December 31, 2024:
Fair Value Measurements Using:
AssetsFair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Cash Equivalents:
Money market funds$63,945 $63,945 $— $— 
Certificates of deposit245 — 245 — 
$64,190 $63,945 $245 $— 
Investments:Fair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Corporate bonds and commercial paper$46,702 $— $46,702 $— 
Certificates of deposit14,092 — 14,092 — 
U.S. government securities26,922 — 26,922 — 
$87,716 $— $87,716 $— 
The following table details the fair value hierarchy of the Company's financial assets measured at fair value on a recurring basis as of December 31, 2023:
Fair Value Measurements Using:
AssetsFair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Cash Equivalents:
Money market funds$86,611 $86,611 $— $— 
Investments:Fair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Corporate bonds and commercial paper$31,852 $— $31,852 $— 
Certificates of deposit9,321 — 9,321 — 
U.S. government securities53,055 — 53,055 — 
$94,228 $— $94,228 $— 
The Company determines the fair value of the vast majority of its debt investment holdings based on pricing from its pricing vendors. The valuation techniques used to measure the fair value of financial instruments having Level II inputs were derived from non-binding consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. Such market prices may be quoted prices in active markets for identical assets (Level I inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level II inputs).
v3.25.0.1
Cash, Cash Equivalents and Investments
12 Months Ended
Dec. 31, 2024
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Investments Cash, Cash Equivalents and Investments
The Company's cash, cash equivalents and investments as of December 31, 2024 and 2023 consisted primarily of cash, U.S. government securities, corporate bonds, commercial paper, certificates of deposit, money market funds and other equity investments.
The Company classifies its debt investments as available-for-sale at the time of purchase and reevaluates such classification as of each balance sheet date. All debt investments are recorded at estimated fair value. Unrealized gains and losses on available-for-sale investments are included in accumulated other comprehensive income (loss), a component of stockholders' equity. If the Company does not expect to recover the entire amortized cost basis of the available-for-sale debt security, it considers the available-for-sale debt security to be impaired. For individual debt securities classified as available-for-sale and deemed impaired, the Company assesses whether such decline has resulted from a credit loss or other factors. Impairment relating to credit losses is recorded through a reserve, limited to the amount that the fair value is less than the amortized cost basis. Impairment is reported in other income (expense), net on the consolidated statements of comprehensive loss. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net on the consolidated statements of comprehensive loss. Interest, amortization of premiums and accretion of discount on all debt investments classified as available-for-sale are also included as a component of other income (expense), net on the consolidated statements of comprehensive loss. Based on the Company's assessment, no impairments for credit losses were recognized during the years ended December 31, 2024 and 2023.
The Company has invested in a private financial technology investment fund, classified as an equity investment. Equity investments without a readily determinable fair value, where the Company has no influence over the operating and financial policies of the investee, are recorded at cost, less impairment and adjusted for subsequent observable price changes obtained from orderly transactions for identical or similar investments issued by the same investee. An impairment charge to current earnings is recorded when the cost of the investment exceeds its fair value and this condition is determined to be other-than-temporary. During the years ended December 31, 2024 and December 31, 2023, the Company determined there was a zero and $0.1 million other-than-temporary impairment, respectively, on its equity investment. This equity investment had a carrying amount of $0.3 million and $0.1 million as of December 31, 2024 and December 31, 2023, respectively.
As of December 31, 2024 and 2023, the Company's cash was $294.4 million and $143.0 million, respectively.
A summary of the Company's cash equivalents and investments that are carried at fair value as of December 31, 2024 is as follows:
Cash Equivalents:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Money market funds$63,945 $— $— $63,945 
Certificates of deposit245 — — 245 
$64,190 $— $— $64,190 
Investments:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Corporate bonds and commercial paper$46,626 $104 $(28)$46,702 
Certificates of deposit14,076 20 (4)14,092 
U.S. government securities26,917 22 (17)$26,922 
$87,619 $146 $(49)$87,716 
A summary of the Company's cash equivalents and investments that are carried at fair value as of December 31, 2023 is as follows:
Cash Equivalents:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Money market funds$86,611 $— $— $86,611 
Investments:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Corporate bonds and commercial paper$31,979 $$(130)$31,852 
Certificates of deposit9,337 — (16)9,321 
U.S. government securities53,208 — (153)53,055 
$94,524 $$(299)$94,228 
Investments may be sold or may settle at any time, without significant penalty, for use in current operations or for other purposes, even if they have not yet reached maturity. As a result, the Company classifies its investments, including investments with maturities beyond twelve months, as current assets on the consolidated balance sheets.
The following table summarizes the estimated fair value of the Company's debt investments, designated as available-for-sale and classified by the contractual maturity date of the investments as of the dates shown:
December 31,
 20242023
Due within one year or less$49,460 $87,133 
Due after one year through two years38,256 7,095 
$87,716 $94,228 
The Company has certain available-for-sale debt investments in a gross unrealized loss position. The Company regularly reviews its debt investments for impairment resulting from credit loss using both qualitative and quantitative criteria, as necessary, based on the composition of the portfolio at period end. The Company considers factors such as the length of time and extent to which the market value has been less than the cost, the financial position and near-term prospects of the issuer or whether the Company has the intent to or it is more likely than not it will be required to sell the investments before recovery of the investments' amortized-cost basis. If the Company determines that impairment exists in one of these investments, the respective investment would be written down to fair value. For debt securities, the portion of the write-down related to credit loss would be recognized in other income, net on the consolidated statements of comprehensive loss if the intent of the Company was to sell the investment before recovery. Any portion not related to credit loss would be included in accumulated other comprehensive income (loss) in the consolidated statements of comprehensive loss. Because the Company does not intend to sell any investments which have an unrealized loss position at this time, and it is not more likely than not that the Company will be required to sell the investment before recovery of its amortized cost basis, which may be maturity, the reserve for available-for-sale debt securities was zero as of December 31, 2024 and 2023.
The following table presents the fair values and the gross unrealized losses of these available-for-sale debt investments as of December 31, 2024, aggregated by investment category and the length of time that individual securities have been in a continuous loss position:
Less than 12 months12 months or greater
 Fair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Corporate bonds and commercial paper$19,229 $(28)$— $— 
Certificates of deposit1,722 (4)248 — 
U.S. government securities9,882 (17)— — 
$30,833 $(49)$248 $— 
The following table presents the fair values and the gross unrealized losses of these available-for-sale debt investments as of December 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position:
Less than 12 months12 months or greater
Fair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Corporate bonds and commercial paper$12,060 $(39)$18,525 $(91)
Certificates of deposit1,999 (5)2,215 (11)
U.S. government securities18,140 (42)32,421 (111)
$32,199 $(86)$53,161 $(213)
v3.25.0.1
Deferred Solution and Other Costs
12 Months Ended
Dec. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Deferred Solution and Other Costs Deferred Solution and Other Costs
Deferred solution and other costs, current portion and net of current portion, consisted of the following:
 December 31,
 20242023
Deferred solution costs$16,741 $18,527 
Deferred commissions9,870 8,994 
Deferred solution and other costs, current portion$26,611 $27,521 
Deferred solution costs$2,628 $4,476 
Deferred commissions25,488 21,614 
Deferred solution and other costs, net of current portion$28,116 $26,090 
v3.25.0.1
Property and Equipment
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
Property and Equipment Property and Equipment
Property and equipment consisted of the following:
 December 31,
 20242023
Computer hardware and equipment$70,390 $67,942 
Purchased software and licenses11,053 12,075 
Furniture and fixtures10,194 9,997 
Leasehold improvements30,496 28,217 
122,133 118,231 
Accumulated depreciation(90,605)(77,053)
Property and equipment, net$31,528 $41,178 
Depreciation expense was $16.6 million, $19.9 million and $17.7 million for the years ended December 31, 2024, 2023 and 2022, respectively.
v3.25.0.1
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
The carrying amount of goodwill was $512.9 million at both December 31, 2024 and 2023. Goodwill represents the excess purchase price over the fair value of net assets acquired. The annual impairment test was performed as of October 31, 2024. No impairment of goodwill was identified during 2024, nor has any impairment of goodwill been recorded to date.
Intangible assets at December 31, 2024 and 2023 were as follows:
As of December 31, 2024As of December 31, 2023
Gross AmountAccumulated AmortizationNet Carrying AmountGross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$1,495 $(1,401)$94 $55,540 $(46,065)$9,475 
Non-compete agreements— — — 12,020 (10,058)1,962 
Trademarks— — — 19,870 (14,266)5,604 
Acquired technology 150,097 (112,791)37,306 150,097 (90,776)59,321 
Capitalized software development costs81,080 (23,847)57,233 56,147 (10,937)45,210 
$232,672 $(138,039)$94,633 $293,674 $(172,102)$121,572 
The estimated useful lives and weighted average remaining amortization periods for intangible assets at December 31, 2024 are as follows (in years):
Estimated Useful Life Weighted Average Remaining Amortization Period
Customer relationships40.3
Acquired technology
5 - 7
1.9
Capitalized software development costs53.8
Total3.1
The Company recorded intangible assets from various prior business combinations as well as capitalized software development costs. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which range from four to seven years. Amortization expense included in cost of revenues on the consolidated statements of comprehensive loss was $35.2 million, $31.1 million and $25.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Amortization expense included in operating expenses on the consolidated statements of comprehensive loss was $17.0 million, $20.7 million and $18.2 million for the years ended December 31, 2024, 2023 and 2022, respectively.
The estimated future amortization expense related to intangible assets as of December 31, 2024 was as follows:
Amortization
Year Ended December 31,
2025$37,359 
202630,791 
202714,855 
20288,586 
20293,042 
Total amortization$94,633 
v3.25.0.1
Accrued Liabilities
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Accrued Liabilities Accrued Liabilities
Accrued liabilities consisted of the following:
 December 31,
 20242023
Accrued data center equipment, software and services$2,704 $1,922 
Accrued transaction processing fees5,904 5,183 
Accrued professional services2,748 2,405 
Lease and other restructuring charges1,868 2,428 
Other5,015 4,533 
Accrued liabilities$18,239 $16,471 
v3.25.0.1
Leases
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Leases Leases
The Company leases office space under non-cancellable operating leases for its corporate headquarters in Austin, Texas in two adjacent buildings under separate lease agreements. Pursuant to the first agreement, the Company leases office space with an initial term that expires on April 30, 2028, with the option to extend the lease for an additional ten-year term. The Company is not reasonably certain to exercise the renewal, therefore no amounts related to this option is recognized as part of lease liabilities or right of use assets. Pursuant to the second agreement, the Company leases office space with lease terms of approximately ten years, with an option to extend the lease on the second building from five to ten years. The Company also leases office space in other U.S. cities located in Nebraska, Iowa, North Carolina and Minnesota. Internationally, the Company leases offices in India, Australia and the United Kingdom. The Company believes its current facilities will be adequate for its needs for the foreseeable future.
Rent expense under operating leases was $5.7 million, $5.3 million and $7.3 million for the years ended December 31, 2024, 2023 and 2022, respectively.
The components of lease costs, lease term and discount rate as of December 31 were as follows:
Operating Leases
202420232022
Lease expense:
Operating lease expense$9,360 $9,257 $11,002 
Sublease income(949)(1,004)(1,308)
Total lease expense $8,411 $8,253 $9,694 
Other information:
Cash paid for operating lease liabilities$13,220 $12,678 $12,886 
Right of use assets obtained in exchange for operating lease liabilities for the years ended December 31, 2024, 2023 and 2022
$2,605 $3,292 $917 
Weighted-average remaining lease term - operating leases6.2 years6.6 years7.5 years
Weighted-average discount rate - operating leases6.0 %6.2 %5.2 %
Maturities of the Company's operating lease liabilities for lease terms in excess of one year at December 31, 2024 were as follows:
Operating Leases
Year Ended December 31,
2025$12,500 
202610,217 
20278,915 
20285,782 
20294,276 
Thereafter15,712 
Total lease payments57,402 
Less: imputed interest(8,729)
Total operating lease liabilities$48,673 
The Company is reasonably certain to exercise the renewal options on two of its buildings. The future operating lease payments include $15.3 million in optional lease renewals. Additionally, the Company's operating lease liabilities include $10.9 million and right of use assets include $8.1 million in optional lease renewals.
As of December 31, 2024 the Company has active sublease agreements related to excess office space in North Carolina, Texas, Georgia, and Nebraska.
The Company has exited and made available for sublease certain leased office spaces, and updated assessments of previously exited leased office spaces. As a result, the Company evaluated the recoverability of its right of use and other lease related assets and determined that their carrying values were not fully recoverable. The Company calculated the impairment by comparing the carrying amount of the asset group to its estimated fair value using a discounted cash flow model. During the year ended December 31, 2024, impairment charges of $0.8 million were recorded to right of use assets and charges of $0.1 million were recorded to property and equipment. During the year ended December 31, 2023, an impairment of $1.9 million was recorded to right of use assets, $0.2 million was recorded to property and equipment and an additional $0.3 million was recorded to accrued liabilities and other long-term liabilities for expected expenses and fees associated with exiting the leased office space. These charges were recorded within operating expenses on the consolidated statements of comprehensive loss.
v3.25.0.1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
The Company has non-cancelable contractual commitments related to the 2026 Notes and the 2025 Notes (each as defined below) as well as the related interest. The interest on the 2026 Notes is payable semi-annually on June 1 and December 1 of each year. The interest on the 2025 Notes is payable semi-annually on May 15 and November 15 of each year. The Company also has non-cancelable contractual commitments for certain third-party products, stadium sponsorship costs, commitment fees associated with the Company's Revolving Credit Agreement, co-location and third-party public cloud service provider fees and other product costs. Several of these purchase commitments for third-party products contain both a contractual minimum obligation and a variable obligation based upon usage or other factors which can change on a monthly basis. The estimated amounts for usage and other factors are not included within the table below.
Future minimum contractual commitments that have initial non-cancelable terms in excess of one year at December 31, 2024 were as follows:
Contractual Commitments
Year Ended December 31,
2025$265,876 
2026352,492 
202711,298 
20284,621 
2029219 
Total commitments$634,506 
Legal Proceedings
From time to time, the Company is involved in legal proceedings arising in the ordinary course of its business. The Company is not presently a party to any legal proceedings that it believes, if determined adversely to the Company, would have a material adverse effect on the Company.
Gain Contingencies
From time to time the Company may realize a gain contingency, however, recognition will not occur until cash is received. The Company received a favorable settlement of an ordinary course dispute and recognized a gain of $0.7 million during the year ended December 31, 2022. This gain was included in interest and other income in the consolidated statements of comprehensive loss.
Loss Contingencies
In the ordinary course of business, the Company is subject to loss contingencies that cover a range of matters. An estimated loss from a loss contingency, such as a legal proceeding or claim, is accrued if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated.
Severance and Other Related Costs
During the third quarter of 2024, the Company incurred contractual severance-related expenses for the departure of an executive officer. Additionally, during the second half of 2024, the Company incurred contractual severance-related charges for organizational changes intended to enable the Company to scale the business more efficiently that are included within lease and other restructuring charges on the consolidated statements of comprehensive loss. The severance charges relating to the executive departure are anticipated to be paid out over the 18 months following the executive's departure, consistent with previously disclosed employment arrangements. The remaining severance-related charges associated with organizational changes were substantially paid out in fiscal year 2024. During 2024 cash payments of $1.0 million were made for the incurred costs. The remaining liability related to these charges is included in accrued compensation on the consolidated balance sheets in the amount of $0.9 million as of December 31, 2024.
v3.25.0.1
Debt
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Debt Debt
The following table presents details of the Company's convertible senior notes outstanding as of December 31, 2024, which are further discussed below (principal in thousands):
Date Issued
Maturity Date (1)
Principal
Interest Rate per Annum
Conversion Rate for Each $1,000 Principal (2)
Initial Conversion Price per Share
2026 Notes
June 1, 2019
June 1, 2026
$303,995 0.75 %$11.2851 $88.61 
2025 NotesNovember 15, 2020November 15, 2025$191,000 0.125 %$7.1355 $140.14 
____________________________________________________________________________
(1) Unless earlier converted or repurchased in accordance with their terms prior to such date
(2) Subject to adjustment upon the occurrence of certain specified events
As further defined and described below, the 2026 Notes and the 2025 Notes are collectively referred to as the Notes.
In June 2019, the Company issued $316.3 million principal amount of convertible senior notes due in June 2026, or the 2026 Notes. Interest is payable semi-annually on June 1 and December 1 of each year, commencing on December 1, 2019.
In November 2020, the Company issued $350.0 million principal amount of convertible senior notes due in November 2025, or the 2025 Notes. Interest is payable semi-annually on May 15 and November 15 of each year, commencing on May 15, 2021.
In March 2023, the Company repurchased $12.3 million in aggregate principal amount of the 2026 Notes for $10.7 million in cash and repurchased $159.0 million in aggregate principal amount of the 2025 Notes for $138.4 million in cash. The partial repurchase of the 2026 Notes and 2025 Notes resulted in a $19.9 million gain on early debt extinguishment, of which $1.8 million consisted of unamortized debt issuance costs. This gain was recorded within other income (expense) on the consolidated statements of comprehensive loss. The Company may repurchase additional 2025 Notes and/or 2026 Notes from time to time through open market purchases, block trades, and/or privately negotiated transactions, in compliance with applicable securities laws and other legal requirements. The timing, volume, and nature of the repurchases will be determined by the Company based on the capital needs of the business, market conditions, applicable legal requirements, and other factors.
The Notes are the Company's senior unsecured obligations and rank senior in right of payment to any of the Company's indebtedness that is expressly subordinated in right of payment to the Notes, rank equally in right of payment with any of the Company's indebtedness that is not so subordinated, are effectively junior in right of payment to any of the Company's secured indebtedness to the extent of the value of the assets securing such indebtedness and are structurally junior to all indebtedness and other liabilities (including trade payables) of the Company's current and future subsidiaries.
On or after June 5, 2023 or November 20, 2023 for the 2026 Notes and 2025 Notes, respectively, the Company may redeem for cash all or any portion of the Notes, at the Company's option, if the last reported sale price of the Company's common stock has been at least 130% of the conversion price in effect for at least 20 trading days (whether or not consecutive) during any 30-consecutive trading-day period. If the Company calls any or all of the Notes for redemption, holders may convert all or any portion of their Notes at any time prior to the close of business on the scheduled trading day prior to the redemption date, even if the Notes are not otherwise convertible at such time. After that time, the right to convert such Notes will expire, unless the Company defaults in the payment of the redemption price, in which case a holder of the Notes may convert all or any portion of its Notes until the redemption price has been paid or duly provided for.
On or after March 1, 2026 or August 15, 2025 for the 2026 Notes and 2025 Notes, respectively, holders may convert all or any portion of their Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the succeeding conditions described herein. Upon conversion, the Company will pay or deliver cash, shares of its common stock or a combination of cash and shares of its common stock, at its election, as described in the indentures governing the Notes.
Holders may convert their Notes at their option at any time prior to the close of business on the business day immediately preceding March 1, 2026 or August 15, 2025 for the 2026 Notes and 2025 Notes, respectively, only under the following circumstances:
during any calendar quarter commencing after the calendar quarter ending on September 30, 2019 or March 30, 2021 (and only during such calendar quarter), for the 2026 Notes and 2025 Notes, respectively, if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during the five consecutive business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the conversion rate on each such trading day; or
upon the occurrence of specified corporate events.
If a fundamental change (as defined in the relevant indenture governing each of the Notes) occurs prior to the maturity date, holders of each of the Notes may require the Company to repurchase all or a portion of their notes for cash at a repurchase price equal to 100% of the principal amount of the Notes, plus any accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
The Notes consist of the following:
As of December 31, 2024As of December 31, 2023
2026 Notes2025 Notes2026 Notes2025 Notes
Principal$303,995 $191,000 $303,995 $191,000 
Unamortized debt issuance costs(1,880)(669)(3,133)(1,398)
Net carrying amount$302,115 $190,331 $300,862 $189,602 
As of December 31, 2024, the if-converted value of the 2026 Notes exceeded the principal amount by $39.2 million, and the if-converted value of the 2025 Notes did not exceed the principal amount. The if-converted value was determined based on the closing price of the Company's stock on December 31, 2024.
Capped Call Transactions
In connection with the issuance of the Notes, the Company entered into two separate capped call transactions, or the Capped Calls, with one or more counterparties. The Capped Calls associated with the 2026 Notes have an initial strike price of $88.6124 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2026 Notes. The Capped Calls associated with the 2025 Notes have an initial strike price of $140.1443 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2025 Notes. The Capped Calls associated with the 2026 Notes have an initial cap price of $139.00 per share. The Capped Calls associated with the 2025 Notes have an initial cap price of $211.54 per share. The Capped Calls are expected to offset the potential dilution to the common stock upon any conversion of the Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of the Notes in the event the market price per share of common stock is greater than the strike price of the Capped Call, with such offset subject to a cap. If, however, the market price per share of the common stock exceeds the cap price of the Capped Calls, there would be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that the then-market price per share of the common stock exceeds the cap price. As the Capped Calls are considered indexed to the Company's stock and are considered equity classified, they are recorded in stockholders' equity on the consolidated balance sheet and are not accounted for as derivatives. The cost of $40.8 million incurred in connection with the Capped Calls associated with the 2026 Notes was recorded as a reduction to additional paid-in capital. The cost of $39.8 million incurred in connection with the Capped Calls associated with the 2025 Notes was recorded as a reduction to additional paid-in capital.
In March 2023, in connection with the partial repurchase of the Notes, the Company terminated the Capped Calls in a notional amount corresponding to the aggregate principal amount of the Notes that were repurchased. As a result of the termination of the related Capped Calls, the Company received cash payments of $0.1 million. The proceeds were recorded as an increase to additional paid-in capital on the consolidated balance sheets.
Revolving Credit Agreement
On July 29, 2024, the Company entered into a five-year secured Revolving Credit Agreement with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC and Texas Capital Bank. The Revolving Credit Agreement provides for a revolving line of credit of up to $125.0 million, which may be drawn upon as revolving loans, swingline loans or letter of credit issuances, with sublimits (i) in the case of swingline loans, in an amount up to $20.0 million and (ii) in the case of letters of credit, in an amount up to $10.0 million. Borrowings under the Revolving Credit Agreement may, at the Company's election, bear interest quarterly at either (a) the base rate plus the applicable margin ("Base Rate Loans") or (b) the adjusted term secured overnight financing rate (the "SOFR"), plus the applicable margin (the "Adjusted Term SOFR Loans"). The applicable margin ranges from 0.75% to 1.50% per annum for Base Rate Loans and 1.75% to 2.50% per annum for Adjusted Term SOFR loans. A commitment fee accrues at a rate ranging from 0.15% to 0.30% per annum, based on the Company's consolidated total net leverage ratio, of the average daily unused portion of the commitment of the lenders.
The Revolving Credit Agreement contains customary representations, warranties, affirmative and negative covenants, including covenants which restrict the ability of the Company, or any of its subsidiaries to, among other things, create liens, incur additional indebtedness and engage in certain other transactions, in each case subject to certain exclusions. In addition, the Revolving Credit Agreement contains certain financial covenants which become effective in the event the Company's liquidity (as defined in the Revolving Credit Agreement) falls below specified levels. The Revolving Credit Agreement contains customary events of default relating to, among other things, payment defaults, breach of covenants, cross-default acceleration to material indebtedness, bankruptcy-related defaults, judgment defaults, and the occurrence of certain change of control events. The occurrence of an event of default may result in the termination of the Revolving Credit Agreement and acceleration of repayment obligations with respect to any outstanding principal amounts. As of December 31, 2024, the Company was in compliance with all financial covenants in the Revolving Credit Agreement.
As of December 31, 2024, $0.9 million of unamortized debt issuance cost related to the Revolving Credit Agreement is included in prepaid expense and other current assets and other long-term assets in the consolidated balance sheets. As of December 31, 2024, the Company had no outstanding borrowings under the Revolving Credit Agreement.
Interest Expense on Debt
The following table sets forth expenses related to the Notes and Revolving Credit Agreement:
Year Ended December 31,
202420232022
Contractual interest expense$2,681 $2,532 $2,892 
Amortization of debt issuance costs2,059 2,104 2,719 
Total$4,740 $4,636 $5,611 
Debt issuance costs are amortized on a straight-line basis over the expected life of the Notes and the Revolving Credit Agreement, respectively. For the Notes, the straight-line basis approximates the effective interest method. As of December 31, 2024, the remaining period over which the debt issuance costs will be amortized for the 2026 Notes and 2025 Notes was 1.4 years and 0.9 years, respectively.
v3.25.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
In March 2014, the Company's board of directors approved the 2014 Equity Incentive Plan, or 2014 Plan. The 2014 Plan terminated on June 1, 2023, except with respect to the outstanding awards previously granted thereunder. As of June 1, 2023, there were 7,606 shares of common stock that were reserved for issuance pursuant to outstanding awards, assuming maximum performance for any performance-based awards, under the 2014 Plan.
In May 2023, the Company's stockholders approved the 2023 Equity Incentive Plan, or 2023 Plan, with an effective date of June 1, 2023, under which stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and units and other cash-based or stock-based awards may be granted to employees, consultants and directors. At time of approval, up to 14,045 shares of common stock were reserved for issuance under the 2023 Plan, all of which consisted of shares previously reserved for issuance under the 2014 Plan and any shares that would otherwise be returned to the 2014 Plan as a result of the forfeiture, repurchase or termination of awards issued under that plan. The 2023 Plan is a successor to and continuation of the Company's 2014 Plan. As of December 31, 2024, 6,164 shares remain authorized and available for future issuance under the 2023 Plan, assuming attainment of maximum performance for any market stock units or performance stock units.
In March 2014, the Company adopted its ESPP. The plan was implemented starting January 3, 2022, pursuant to which certain participating domestic employees are able to purchase shares of the Company's common stock at a 15% discount of the lower of the market price at the beginning or end of the applicable offering period. Offering periods commence on each June 1 and December 1. The Board provided for a share reserve with respect to the ESPP of 800 shares. The ESPP contains a provision that automatically increases the shares available for issuance under the plan on January 1 of each year through 2024, by an amount equal to the lesser of (a) 500 shares, (b) 1% of the number of shares issued and outstanding on the immediately preceding December 31, or (c) such other amount as may be determined by the Company's board of directors. As of December 31, 2024, 1,224 shares remain authorized and available for future issuance under the ESPP.
Stock-based compensation expense was recorded in the following cost and expense categories on the Company's consolidated statements of comprehensive loss:
 Year Ended December 31,
 202420232022
Cost of revenues$11,821 $13,346 $12,262 
Sales and marketing16,779 16,771 15,379 
Research and development16,456 15,157 13,987 
General and administrative44,159 33,914 23,529 
Total stock-based compensation expense$89,215 $79,188 $65,157 
Stock-based compensation capitalized as an asset was $5.1 million, $5.3 million and $3.9 million in the years ended December 31, 2024, 2023 and 2022, respectively.
Stock Options
There were no stock options granted during the years ended December 31, 2024, 2023 or 2022.
Stock option activity was as follows:
Number of
Options
Weighted Average
Exercise Price
Balance as of January 1, 2022363 $34.42 
Granted— — 
Exercised(27)26.06 
Forfeited— — 
Expired(12)35.80 
Balance as of December 31, 2022324 35.07 
Granted— — 
Exercised(74)30.91 
Forfeited— — 
Expired(4)27.86 
Balance as of December 31, 2023246 36.43 
Granted— — 
Exercised(234)35.90 
Forfeited— — 
Expired — — 
Balance as of December 31, 202412 $47.00 
The summary of stock options outstanding as of December 31, 2024 is as follows:
 Options Outstanding and Exercisable
Exercise PricesNumber of
Options
Weighted Average
Exercise Price
Weighted Average
Remaining
Contractual Life
(in years)
$47.00
12 $47.00 0.2
The aggregate intrinsic value of stock options exercised during each of the years ended December 31, 2024, 2023 and 2022 was $1.5 million, $0.4 million and $0.6 million, respectively. The total fair value of stock options vested during each of the years ended December 31, 2024, 2023 and 2022 was zero, zero and $0.01 million, respectively.
As of December 31, 2024, the aggregate intrinsic value of options outstanding was $0.6 million. As of December 31, 2024, all options are vested, therefore the unrecognized stock-based compensation expense related to stock options is zero.
Restricted Stock Units
Restricted stock unit activity was as follows:
Number of
Shares
Weighted Average
Grant Date Fair Value
Nonvested as of January 1, 20221,620 $90.75 
Granted2,186 45.62 
Vested(609)82.50 
Forfeited(253)78.70 
Nonvested as of December 31, 20222,944 59.99 
Granted1,981 32.31 
Vested(963)63.59 
Forfeited(366)48.39 
Nonvested as of December 31, 20233,596 44.96 
Granted1,513 49.30 
Vested(1,231)50.49 
Forfeited(361)45.45 
Nonvested as of December 31, 20243,517 $44.84 
The total fair value of restricted stock units vested during each of the years ended December 31, 2024, 2023 and 2022 was $75.7 million, $32.5 million and $29.1 million, respectively. Total unrecognized stock-based compensation expense related to restricted stock units was $113.1 million, which the Company expects to recognize over a weighted average period of 2.4 years.
Market Stock Units and Performance Stock Units
MSU and PSU activity was as follows:
Number of SharesWeighted Average Grant Date Fair Value
Nonvested as of January 1, 2022281 $59.74 
Granted239 46.75 
Vested— — 
Forfeited(121)41.71 
Nonvested as of December 31, 2022399 57.42 
Granted587 39.59 
Vested(4)23.21 
Forfeited(48)55.55 
Nonvested as of December 31, 2023934 46.45 
Granted389 59.92 
Change in awards based on performance(1)
11 88.40 
Vested(82)45.90 
Forfeited(191)59.12 
Nonvested as of December 31, 20241,061 $49.58 
________________________________________________________________________
(1)Represents the change in the number of MSUs earned based on performance achievement for the performance period.
Significant assumptions used in the Monte Carlo simulation model for the TSR PSUs and MSUs granted during the year ended December 31, 2024, 2023, and 2022 are as follows:
Year Ended December 31,
202420232022
Volatility
53.5 - 54.1%
52.7% - 54.8%
45.4%
Risk-free interest rate
4.2 - 4.5%
3.9% - 4.5%
1.9%
Dividend yield
Longest remaining performance period (in years)333
The total fair value of MSUs and PSUs vested during each of the years ended December 31, 2024, 2023 and 2022 was $5.6 million, $0.1 million and zero, respectively. Total unrecognized stock-based compensation expense related to MSUs and PSUs was $30.4 million, which the Company expects to recognize over a weighted average period of 1.7 years.
Employee Stock Purchase Plan
The following summarizes the assumptions used for estimating the fair value of ESPP purchase rights:
Year Ended December 31,
 202420232022
Risk-free interest rate
4.4 - 5.4%
5.3 - 5.4%
0.3% - 4.7%
Expected life (in years)
0.5
0.5
0.3 - 0.5
Expected volatility
38.4 - 40.8%
37.2 - 66.0%
49.7% - 65.6%
Dividend yield
Grant date fair value per share
$16.55 - $28.10
$9.71 - $9.87
$9.45 - $17.30
During the year ended December 31, 2024, the Company's employees purchased 150 shares under the ESPP at a weighted-average price of $39.04 per share, resulting in cash proceeds of $5.9 million. Total unrecognized stock-based compensation expense related to the ESPP was $1.0 million, which the Company expects to recognize over a weighted average period of 0.4 years.
v3.25.0.1
Provision for Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Provision for Income Taxes Provision for Income Taxes
The U.S. and non-U.S. components of loss before income taxes consisted of the following:
 December 31,
 20242023
U.S.$(38,615)$(64,164)
Non-U.S.7,755 2,342 
Loss before income taxes$(30,860)$(61,822)
The components of the Company's provision for income taxes consisted of the following:
 Year Ended December 31,
 202420232022
Current taxes:   
Federal$— $— $— 
Foreign2,151 1,976 959 
State3,025 660 1,268 
Total current taxes$5,176 $2,636 $2,227 
Deferred taxes:   
Federal$1,427 $420 $420 
Foreign276 (251)(355)
State797 757 616 
Total deferred taxes2,500 926 681 
Provision for income taxes $7,676 $3,562 $2,908 
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. In the current year, the Company reclassified certain prior period items in the deferred tax footnote to adjust the current year presentation in various components of its deferred tax assets. Significant components of the Company's deferred taxes consisted of the following:
 December 31,
 20242023
Deferred tax assets:
NOL and credit carryforwards$116,084 $128,670 
Deferred revenue26,069 22,802 
Accrued expenses and other7,190 6,285 
Stock-based compensation11,080 11,425 
Lease liabilities11,633 13,600 
Interest expense carryforwards— 6,202 
Convertible debt hedge2,957 5,727 
IRC Section 174 expenditures73,860 56,711 
Total deferred tax assets248,873 251,422 
Deferred tax liabilities: 
Deferred expenses(17,858)(14,960)
Depreciation and amortization(11,441)(17,491)
Capitalized software(1,690)(1,694)
Right of use assets(7,166)(8,497)
Total deferred tax liabilities(38,155)(42,642)
Deferred tax assets less tax liabilities210,718 208,780 
Less: valuation allowance(217,053)(212,614)
Net deferred tax liability$(6,335)$(3,834)
The Company had federal net operating loss carryforwards of approximately $438.4 million and $504.0 million at December 31, 2024 and 2023, respectively, of which $4.6 million will expire at various dates beginning in 2027, if not utilized, and $433.8 million have an indefinite carryforward period. Federal net operating losses generated during and after the year ended December 31, 2018 will have an indefinite carryforward period. The Company also held federal R&D tax credits of $8.9 million and state tax credits of $0.2 million for the year ended December 31, 2024, and federal R&D tax credits of $8.9 million and state tax credits of $0.3 million for the year ended December 31, 2023. The federal and state tax credit carry overs will begin to expire in 2033, if not utilized.
The Company has established a valuation allowance due to uncertainties regarding the realization of deferred tax assets based on the Company's lack of earnings history. During 2024, the valuation allowance increased by approximately $4.4 million due to continuing operations.
At December 31, 2024, the Company did not provide any U.S. income or foreign withholding taxes on approximately $14.5 million of foreign subsidiaries' undistributed earnings, as such earnings have been retained and are intended to be indefinitely reinvested. It is not practicable to estimate the amount of any taxes that would be payable upon remittance of these earnings, because such tax, if any, is dependent upon circumstances existing if and when remittance occurs.
The Company's provision for income taxes attributable to continuing operations differs from the expected tax benefit amount computed by applying the statutory federal income tax rate of 21% to income before taxes for each of the years ended December 31, 2024, 2023, and 2022, respectively, primarily as a result of the following:
 Year Ended December 31,
 202420232022
Income tax at U.S. statutory rate21.0 %21.0 %21.0 %
Effect of: 
Increase in deferred tax valuation allowance(26.4)(0.7)(14.8)
Stock compensation(0.2)(12.4)(4.8)
Acquisitions— — (0.2)
R&D credit— — (2.4)
State taxes, net of federal benefit1.3 4.5 0.6 
Change in uncertain tax positions(1.2)0.4 1.5 
Executive compensation(13.5)(4.8)(1.8)
GILTI inclusion(2.0)— (1.6)
Foreign NOL write-off— (14.5)— 
Federal return to provision— 2.7 — 
Other permanent items(2.0)(2.0)(0.2)
Income tax provision effective rate(23.1)%(5.8)%(2.7)%
The total amount of uncertain tax positions as of December 31, 2024 and 2023 was $1.1 million and $0.7 million, respectively. The reconciliation of uncertain tax positions at the beginning and end of the year is as follows:
Year Ended December 31,
20242023
Beginning balance$720 $977 
Gross increase (decrease) related to prior year positions38 (510)
Gross increase related to current year positions338 253 
Ending balance$1,096 $720 
At December 31, 2024, approximately $1.1 million would reduce the Company's annual effective tax rate, if recognized. As of December 31, 2024, the Company had no accrued interest. The Company does not believe it is reasonably possible that any of its unrecognized tax positions will be resolved within the next 12 months.
The Company files income tax returns in the U.S. federal jurisdiction, several state jurisdictions, and in each foreign jurisdiction in which we have operations. With few exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for years before 2021. Operating losses and credits generated in years prior to 2021 remain open to adjustment until the statute of limitations closes for the tax year in which the net operating losses and credits are utilized. The tax years 2021 through 2024 remain open to examination by all the major taxing jurisdictions to which the Company is subject.
v3.25.0.1
Employee Benefit Plan
12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Employee Benefit Plan Employee Benefit Plan
In January 2009, the Company adopted a 401(k) retirement savings plan, or 401(k) Plan, covering substantially all employees. The 401(k) Plan also provides for employer contributions to be made at the Company's discretion.
The Company makes matching contributions equal to 50% of employee contributions, up to 6% of each participant's compensation. Employees are eligible to participate upon date of hire and are immediately vested in all matching contributions. The Company's policy prohibits participants from direct investment in shares of its common stock within the plan. The Company's contributions charged to expense were $7.8 million, $7.8 million and $7.2 million for the years ended December 31, 2024, 2023 and 2022, respectively.
v3.25.0.1
Segments and Geographic Information
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segments and Geographic Information Segments and Geographic Information
All revenue-generating activities are directly related to the sale, implementation and support of the Company's solutions in a single operating segment. The Company is a leading provider of digital solutions to financial institutions, FinTechs and Alt-FIs, seeking to incorporate banking into their customer engagement and servicing strategies. The Company derives the majority of its revenues from subscription fees for the use of its solutions hosted in either the Company's third-party data centers or with third-party public cloud service providers, transactional revenue from bill-pay solutions and remote deposit products, revenues for professional services and implementation services related to its solutions and certain third-party related pass-through fees. Additionally, see Note 3 - Revenue for additional information about disaggregated revenue.
The Company's chief operating decision maker, or CODM, is the Chief Executive Officer, and the financial information reviewed by the CODM is presented on a consolidated basis for the single operating segment for purposes of allocating resources, evaluating financial performance and monitoring budget versus actual results based on net income (loss) that is also reported on the consolidated statements of comprehensive loss as net loss. The significant expenses within net income (loss) on which the CODM relies include those that are reported on the consolidated statements of comprehensive loss. The measure of the Company's single operating segment assets is reported on the consolidated balance sheets as total assets. Substantially all of the Company's principal operations, assets and decision-making functions are located in the United States.
v3.25.0.1
Related Parties
12 Months Ended
Dec. 31, 2024
Related Party Transactions [Abstract]  
Related Parties Related Parties
The Company had no material related party transactions for the years ended December 31, 2024, 2023 and 2022.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure      
Net loss $ (38,536) $ (65,384) $ (108,983)
v3.25.0.1
Insider Trading Arrangements
3 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Dec. 31, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Terminated false  
Matthew Flake [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   Matthew Flake, Chief Executive Officer and Chairman, terminated his previously adopted Rule 10b5-1 Trading Plan. Mr. Flake's plan was entered into on August 5, 2024, was set to expire on June 30, 2025 and provided for the potential sale of up to 148,182 shares of the Company's common stock. Subsequently, Mr. Flake entered into a new Rule 10b5-1 Trading Plan on November 12, 2024. Mr. Flake's plan provides for the potential sale of up to 280,213 shares of the Company's common stock between March 6, 2025 and June 30, 2025, assuming maximum attainment of applicable performance measures with respect to vesting of performance stock unit or market stock unit awards during the specified period. The actual number of shares to be sold under the 10b5-1 Plan will depend on the achievement of applicable performance conditions under the performance or market stock units less any shares sold pursuant to mandatory sell-to-cover transactions not covered by the plan related to withholding taxes
Jonathan Price [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Jonathan Price, Chief Financial Officer, terminated his previously adopted Rule 10b5-1 Trading Plan. Mr. Price's plan was entered into on March 12, 2024, was set to expire on March 7, 2025 provided for the potential sale of up to 34,117 shares of the Company's common stock, including the potential exercises of vested stock options and the associated sale of up to 11,641 shares of common stock. Subsequently, Mr. Price entered into a new Rule 10b5-1 Trading Plan on November 22, 2024. Mr. Price's plan provides for the potential sale of up to 120,068 shares of the Company's common stock, including the potential exercises of vested stock options and the associated sale of up to 11,641 shares of common stock between February 21, 2025 and December 31, 2025, assuming maximum attainment of applicable performance measures with respect to vesting of performance stock unit or market stock unit awards during the specified period. The actual number of shares to be sold under the 10b5-1 Plan will depend on the achievement of applicable performance conditions under the performance or market stock units less any shares sold pursuant to mandatory sell-to-cover transactions not covered by the plan related to withholding taxes.
Arrangement Duration 313 days  
Kirk Coleman [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Kirk Coleman, President, entered into a Rule 10b5-1 Trading Plan on November 22, 2024. Mr. Coleman's plan provides for the potential sale of up to 142,268 shares of the Company's common stock between February 21, 2025 and September 30, 2025, assuming maximum attainment of applicable performance measures with respect to vesting of performance stock unit or market stock unit awards during the specified period. The actual number of shares to be sold under the 10b5-1 Plan will depend on the achievement of applicable performance conditions under the performance or market stock units less any shares sold pursuant to mandatory sell-to-cover transactions not covered by the plan related to withholding taxes.
Name Kirk Coleman  
Title President  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 22, 2024  
Expiration Date September 30, 2025  
Arrangement Duration 221 days  
Aggregate Available 142,268 142,268
Michael S. Kerr [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
Michael Kerr, Senior Vice President, General Counsel, entered into a Rule 10b5-1 Trading Plan on December 13, 2024. Mr. Kerr's plan provides for the potential sale of up to 14,109 shares of the Company's common stock between March 14, 2025 and September 30, 2025, assuming maximum attainment of applicable performance measures with respect to vesting of performance stock unit awards during the specified period. The actual number of shares to be sold under the 10b5-1 Plan will depend on the achievement of applicable performance conditions under the performance stock units less any shares sold pursuant to mandatory sell-to-cover transactions not covered by the plan related to withholding taxes.
Name Michael Kerr  
Title Senior Vice President, General Counsel  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 13, 2024  
Expiration Date September 30, 2025  
Arrangement Duration 200 days  
Aggregate Available 14,109 14,109
Matthew Flake August 2024 Plan [Member] | Matthew Flake [Member]    
Trading Arrangements, by Individual    
Name Matthew Flake  
Title Chief Executive Officer and Chairman  
Rule 10b5-1 Arrangement Terminated true  
Termination Date November 12, 2024  
Aggregate Available 148,182 148,182
Matthew Flake November 2024 Plan [Member] | Matthew Flake [Member]    
Trading Arrangements, by Individual    
Name Matthew Flake  
Title Chief Executive Officer and Chairman  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 12, 2024  
Expiration Date June 30, 2025  
Arrangement Duration 116 days  
Aggregate Available 280,213 280,213
Jonathan Price March 2024 Plan [Member] | Jonathan Price [Member]    
Trading Arrangements, by Individual    
Name Jonathan Price  
Title Chief Financial Officer  
Rule 10b5-1 Arrangement Terminated true  
Termination Date November 22, 2024  
Aggregate Available 34,117 34,117
Jonathan Price November 2024 Plan [Member] | Jonathan Price [Member]    
Trading Arrangements, by Individual    
Name Jonathan Price  
Title Chief Financial Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 22, 2024  
Expiration Date December 31, 2025  
Aggregate Available 120,068 120,068
v3.25.0.1
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
As a provider of SaaS solutions and an extensive user of a variety of technology services, we are subject to numerous risks from cybersecurity threats that have and could adversely affect us; however, to date none have materially affected us or our business strategy, results of operation or financial condition. Cybersecurity threats are ever-present and continuously evolving and we have and will continue to expend considerable resources to deliver solutions that are designed to comply with the stringent security and technical regulations and practices applicable to financial institutions and financial services providers and to safeguard our solutions and information systems against cybersecurity threats. For more information regarding the risks we face from cybersecurity threats, please see "Item 1A. Risk Factors." We have implemented a risk-based approach to identify and assess the cybersecurity threats that have and could affect our business and information systems, which approach is incorporated into our overall enterprise risk management program. Our enterprise risk management program includes a formal, enterprise-wide inventory, categorization and assessment of risks, including risks associated with cybersecurity threats, overseen by the Risk and Compliance Committee, or RACC, of our Board of Directors. This program is managed by our Chief Risk Officer, or CRO, appointed by the RACC, and an Enterprise Risk Oversight Committee consisting of a cross-functional representation of senior leaders including our Chief Information Security Officer, or CISO. Our CRO has over nine years of senior risk management experience at large technology organizations, following a 20-year career in the U.S. Army. Our enterprise risk management team works in partnership with our security, information technology, compliance, internal audit, and third-party risk management functions, which collectively rely on a variety of internal resources and processes, as well as third-party consultants, auditors and applications, to identify, assess and manage cybersecurity risks, including cybersecurity threats related to third-party providers on which we rely. Our enterprise risk management function also extensively consults with senior management across our organization in identifying, assessing and managing risks.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] As a provider of SaaS solutions and an extensive user of a variety of technology services, we are subject to numerous risks from cybersecurity threats that have and could adversely affect us; however, to date none have materially affected us or our business strategy, results of operation or financial condition. Cybersecurity threats are ever-present and continuously evolving and we have and will continue to expend considerable resources to deliver solutions that are designed to comply with the stringent security and technical regulations and practices applicable to financial institutions and financial services providers and to safeguard our solutions and information systems against cybersecurity threats. For more information regarding the risks we face from cybersecurity threats, please see "Item 1A. Risk Factors." We have implemented a risk-based approach to identify and assess the cybersecurity threats that have and could affect our business and information systems, which approach is incorporated into our overall enterprise risk management program. Our enterprise risk management program includes a formal, enterprise-wide inventory, categorization and assessment of risks, including risks associated with cybersecurity threats, overseen by the Risk and Compliance Committee, or RACC, of our Board of Directors. This program is managed by our Chief Risk Officer, or CRO, appointed by the RACC, and an Enterprise Risk Oversight Committee consisting of a cross-functional representation of senior leaders including our Chief Information Security Officer, or CISO.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
Our information security program is managed by a CISO, whose team is responsible for leading our enterprise-wide cybersecurity strategy, policy, standards, architecture and processes. Our CISO has more than 20 years of experience directing disparate teams across application and product security, cyber defense, risk management, information governance, information technology compliance, information technology training and sales. Our CISO is appointed by the RACC, which also oversees the implementation, monitoring and testing of our information security program. Our CISO and CRO provide periodic reports to the RACC, at least quarterly. These reports include updates on the Company's cybersecurity risks and threats, the status of projects to strengthen our information security posture, assessments of the information security program, and the emerging threat landscape. Our CISO and CRO also regularly meet separately with the chair of the RACC to provide similar updates. Our information security program includes incident response procedures designed to facilitate escalation of actual or potential cybersecurity incidents initially to members of our security team, and as appropriate to senior management and the RACC, to allow proper consideration, mitigation and remediation of, as well as evaluation of potential disclosure obligations with respect to, actual or potential cybersecurity incidents. Our information security program is regularly evaluated by internal and external experts with the results of those reviews reported to senior management and the RACC. We also actively engage with key vendors, industry participants and intelligence and law enforcement communities as part of our continuing efforts to evaluate and enhance the effectiveness of our information security program.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our information security program is managed by a CISO, whose team is responsible for leading our enterprise-wide cybersecurity strategy, policy, standards, architecture and processes. Our CISO has more than 20 years of experience directing disparate teams across application and product security, cyber defense, risk management, information governance, information technology compliance, information technology training and sales.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Our CISO is appointed by the RACC, which also oversees the implementation, monitoring and testing of our information security program. Our CISO and CRO provide periodic reports to the RACC, at least quarterly. These reports include updates on the Company's cybersecurity risks and threats, the status of projects to strengthen our information security posture, assessments of the information security program, and the emerging threat landscape. Our CISO and CRO also regularly meet separately with the chair of the RACC to provide similar updates.
Cybersecurity Risk Role of Management [Text Block] Our CISO is appointed by the RACC, which also oversees the implementation, monitoring and testing of our information security program. Our CISO and CRO provide periodic reports to the RACC, at least quarterly. These reports include updates on the Company's cybersecurity risks and threats, the status of projects to strengthen our information security posture, assessments of the information security program, and the emerging threat landscape. Our CISO and CRO also regularly meet separately with the chair of the RACC to provide similar updates. Our information security program includes incident response procedures designed to facilitate escalation of actual or potential cybersecurity incidents initially to members of our security team, and as appropriate to senior management and the RACC, to allow proper consideration, mitigation and remediation of, as well as evaluation of potential disclosure obligations with respect to, actual or potential cybersecurity incidents. Our information security program is regularly evaluated by internal and external experts with the results of those reviews reported to senior management and the RACC. We also actively engage with key vendors, industry participants and intelligence and law enforcement communities as part of our continuing efforts to evaluate and enhance the effectiveness of our information security program.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our information security program is managed by a CISO, whose team is responsible for leading our enterprise-wide cybersecurity strategy, policy, standards, architecture and processes. Our CISO has more than 20 years of experience directing disparate teams across application and product security, cyber defense, risk management, information governance, information technology compliance, information technology training and sales.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our CISO has more than 20 years of experience directing disparate teams across application and product security, cyber defense, risk management, information governance, information technology compliance, information technology training and sales
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Our CISO and CRO provide periodic reports to the RACC, at least quarterly. These reports include updates on the Company's cybersecurity risks and threats, the status of projects to strengthen our information security posture, assessments of the information security program, and the emerging threat landscape. Our CISO and CRO also regularly meet separately with the chair of the RACC to provide similar updates. Our information security program includes incident response procedures designed to facilitate escalation of actual or potential cybersecurity incidents initially to members of our security team, and as appropriate to senior management and the RACC, to allow proper consideration, mitigation and remediation of, as well as evaluation of potential disclosure obligations with respect to, actual or potential cybersecurity incidents. Our information security program is regularly evaluated by internal and external experts with the results of those reviews reported to senior management and the RACC. We also actively engage with key vendors, industry participants and intelligence and law enforcement communities as part of our continuing efforts to evaluate and enhance the effectiveness of our information security program.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.0.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP, and Securities and Exchange Commission, or SEC, requirements.
Principles of Consolidation The consolidated financial statements include the accounts of Q2 Holdings, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses. Significant items subject to such estimates include: revenue recognition; estimate of credit losses; fair value of certain stock awards issued; the carrying value of goodwill; the fair value of acquired intangibles; the useful lives of property and equipment and long-lived intangible assets; the impairment assessment of long-lived assets; and, income taxes. In accordance with GAAP, management bases its estimates on historical experience and on various other assumptions that management believes are reasonable under the circumstances. Management regularly evaluates its estimates and assumptions using historical experience and other factors; however, actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all highly liquid investments acquired with an original maturity of ninety days or less at the date of purchase to be cash equivalents. Cash equivalents are stated at cost or fair value based on the underlying security.
Restricted Cash
Restricted cash consists of deposits held as collateral for the Company's secured letters of credit or bank guarantees issued in place of security deposits for the Company's corporate headquarters and various other leases, deposits held by the Company on behalf of its medical insurance carrier reserved for the use of claim payments and deposits that are restricted to withdrawal or use as of the reporting date under the contractual terms of certain customer arrangements.
Investments
Investments typically include U.S. government securities, corporate bonds, commercial paper, certificates of deposit, money market funds and other equity investments. All debt investments are considered available for sale and are carried at fair value. Equity investments without a readily determinable fair value, where the Company has no influence over the operating and financial policies of the investee, are recorded at cost, less impairment and adjusted for subsequent observable price changes obtained from orderly transactions for identical or similar investments issued by the same investee. Adjustments resulting from impairment, fair value or observable price changes are accounted for in the consolidated statements of comprehensive loss.
Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, restricted cash, investments, accounts receivable and contract assets. The Company's cash and cash equivalents, restricted cash and investments are placed with high credit quality financial institutions and issuers, and at times may exceed federally insured limits. The Company has not experienced any loss relating to cash and cash equivalents or restricted cash in these accounts. The Company provides credit, in the normal course of business, to a majority of its customers. The Company performs periodic credit evaluations of its customers' financial condition and generally does not require collateral.
Contract Assets and Deferred Revenue, Revenues
The timing of revenue recognition, billings and cash collections can result in billed accounts receivable, unbilled receivables, contract assets, and deferred revenues or contract liabilities. Billings scheduled to occur after the performance obligation has been satisfied and revenue recognition has occurred result in contract assets. Contract assets that are expected to be billed during the succeeding twelve-month period are recorded in contract assets, current portion, and the remaining portion is recorded in contract assets, net of current portion on the consolidated balance sheets at the end of each reporting period.
Contract liabilities, or deferred revenues, primarily consist of amounts that have been billed to or received from customers in advance of revenue recognition and prepayments or deposits received from customers in advance for implementation, maintenance and other services, as well as subscription fees. Customer prepayments are generally applied against invoices issued to customers when services are performed and billed. The Company recognizes deferred revenues as revenues when the services are performed and the corresponding revenue recognition criteria are met. Contract liabilities that are expected to be recognized as revenues during the succeeding twelve-month period are recorded in deferred revenues, current portion, and the remaining portion is recorded in deferred revenues, net of current portion, on the consolidated balance sheets at the end of each reporting period.
The Company's payment terms vary by the type and location of its customer and the products or services offered. The period of time between invoicing and when payment is due is not significant. For certain products or services and customer types, the Company requires payment before the products or services are delivered to the customer.
Subscription Revenues
The Company's software solutions are available for use as hosted application arrangements under subscription fee agreements without licensing rights to the software. Subscription fees from these applications, including contractual periodic price increases, are recognized over time on a ratable basis over the customer agreement term beginning on the date the Company's solution is made available to the customer. Amounts that have been invoiced are recorded in accounts receivable and deferred revenues or revenues, depending on whether the revenue recognition criteria have been met. Periodic price increases are estimated at contract inception where appropriate and result in contract assets as revenue recognition may exceed the amount billed early in the contract. Additional fees for monthly usage above the levels included in the standard subscription fee are recognized as revenue in the month when the usage amounts are determined and reported.
A small portion of the Company's customers host and manage the Company's solutions on-premises or in third-party data centers under term license and maintenance agreements. Term licenses sold with maintenance entitle the customer to technical support, upgrades and updates to the software on a when-and-if-available basis. For these customers, the Company recognizes software license revenue once the customer obtains control of the license, which generally occurs at the start of each license term and recognizes the remaining arrangement consideration for maintenance revenue over time on a ratable basis over the term of the software license. Revenues from term licenses and maintenance agreements were not significant in the periods presented.
Transactional Revenues
The Company generates a majority of its transactional revenues based on the number of bill-pay transactions that End Users initiate on its digital banking platform. The Company also generates a portion of its transactional revenues from third-party fees related to End Users utilizing remote deposit products and from fees generated when End Users utilize debit cards integrated with its Helix products. The Company recognizes revenue for transaction services in the month incurred based on actual or estimated transactions.
Services and Other Revenues
Implementation services are required for new digital solutions and other standalone contracts, and there is a significant level of integration and configuration for each customer. The Company's revenue for implementation services is billed upfront and generally recognized over time on a ratable basis over the customer's term for its hosted application agreements. Implementation services for on-premises agreements are recognized at commencement date. Under certain circumstances, the Company has determined that these implementation services qualify as a separate performance obligation in certain markets and geographies, and the implementation services for these agreements are recognized over time as services are performed.

Professional services revenues consist primarily of Integrated Services. Integrated Services revenue is generated from select established customer relationships where the Company has engaged with the customer for more tailored, premium professional services, resulting in a deeper and ongoing level of engagement with them. Professional services revenues also consist of custom services, core conversion services and other general professional services. These revenues are generally billed and recognized when delivered. Other Revenues also include certain third-party related pass-through fees primarily in its Helix business that are not transactional in nature.

Certain out-of-pocket expenses billed to customers are recorded as revenues rather than an offset to the related expense.
Significant Judgments
Performance Obligations and Standalone Selling Price
A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of accounting. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. The Company has contracts with customers that often include multiple performance obligations, usually including multiple subscription and implementation services. For these contracts, the Company accounts for individual performance obligations that are separately identifiable by allocating the contract's total transaction price to each performance obligation in an amount based on the relative standalone selling price, or SSP, of each distinct good or service in the contract. In determining whether implementation services are distinct from subscription services, the Company considers various factors including the significant level of integration, interdependency, and interrelation between the implementation and subscription service, as well as the inability of the customer's personnel or other service providers to perform significant portions of the services. The Company has concluded that the implementation services included in contracts with multiple performance obligations across the majority of its markets and product offerings are not distinct and, as a result, the Company defers any arrangement fees for implementation services and recognizes such amounts over time on a ratable basis as one performance obligation with the underlying subscription revenue for the initial agreement term of the hosted application agreements. The Company has concluded that for some of its products in certain markets the implementation services included in contracts with multiple performance obligations are distinct and, as a result, the Company recognizes implementation fees on such arrangements over time as services are performed.
The majority of the Company's revenue recognized at a particular point in time is for usage revenue, on-premise software licenses and certain professional services. These services are recognized as the customer obtains control of the asset, as services are performed, or the point the customer obtains control of the software.

Judgment is required to determine the SSP for each distinct performance obligation. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The Company determines SSP based on overall pricing objectives and strategies, taking into consideration entity-specific factors, including the value of its contracts, historical standalone sales, customer demographics and the numbers and types of users within its contracts.
Variable Consideration
The Company recognizes usage revenue related to End Users accessing its products in excess of contracted amounts and from fees that End Users generate using the Company's solutions. Judgment is required to determine the accounting for these types of revenue. The Company considers various factors including the degree to which usage is interdependent or interrelated to past services and contractual price per user and their relationship to market terms. The Company has concluded that its usage revenue relates specifically to the transfer of the service to the customer and is consistent with the allocation objective of Topic 606 when considering all of the performance obligations and payment terms in the contract. Therefore, the Company recognizes usage revenue on a monthly or quarterly basis in accordance with the agreement, as determined and reported. This allocation reflects the amount the Company expects to receive for the services for the given period.

The Company sometimes provides credits or incentives to its customers. Known and estimable credits and incentives represent a form of variable consideration, which are estimated at contract inception and generally result in reductions to revenues recognized for a particular contract. These estimates are updated at the end of each reporting period as additional information becomes available. The Company believes that there will not be significant changes to its estimates of variable consideration as of December 31, 2024.
Other Considerations
The Company evaluates whether it is the principal (i.e., reports revenues on a gross basis) or agent (i.e., reports revenues on a net basis) with respect to the vendor reseller agreements pursuant to which the Company resells certain third-party solutions along with its solutions. Generally, the Company reports revenues from these types of contracts on a gross basis, meaning the amounts billed to customers are recorded as revenues, and expenses incurred are recorded as cost of revenues. Where the Company is the principal, it first obtains control of the inputs to the specific good or service and directs their use to create the combined output. The Company's control is evidenced by its involvement in the integration of the good or service on its platform before it is transferred to its customers and is further supported by the Company being primarily responsible to its customers and having a level of discretion in establishing pricing. Revenues provided from agreements in which the Company is an agent are insignificant.
Cost of Revenues
Cost of revenues is comprised primarily of salaries and other personnel-related costs, including employee benefits, bonuses and stock-based compensation, for employees providing services to the Company's customers. This includes the costs of the Company's personnel performing implementation, customer support, third-party data center and customer training activities. Cost of revenues also includes the direct costs of bill-pay and other third-party intellectual property included in the Company's solutions, the amortization of deferred solution and services costs, amortization of certain software development costs, co-location facility costs and depreciation of the Company's data center assets, debit card related pass-through fees, third-party public cloud service providers, an allocation of general overhead costs, the amortization of acquired technology intangibles and referral fees. The Company allocates general overhead expenses to all departments based on the number of employees in each department, which the Company considers to be a fair and representative means of allocation.
The Company capitalizes certain personnel costs directly related to the implementation of its solutions to the extent those costs are recoverable from future revenues. The Company amortizes the costs for an implementation once revenue recognition commences, and the Company amortizes those implementation costs to cost of revenues over the expected period of customer benefit, which has been determined to be the estimated life of the technology. Other costs not directly recoverable from future revenues are expensed in the period incurred. The Company also amortizes the costs capitalized for software development, as described in the next section, to cost of revenues, when products and enhancements are released or made available over the products' estimated economic lives.
Accounts Receivable
Accounts receivable are stated at net realizable value, including both billed and unbilled receivables to customers. Unbilled receivable balances arise primarily when the Company provides services in advance of billing for those services. Generally, billing for revenues related to the number of End Users and the number of transactions processed by the customers' End Users that are included in the customers' minimum subscription fee occurs in the month the revenue is recognized, resulting in accounts receivable. Billing for revenues relating to the number of End Users and the number of transactions processed by the End Users that are in excess of the customers' minimum subscription fees are, generally, billed in the month following the month the revenues were earned, resulting in an unbilled receivable. Unbilled receivables of $7.7 million and $7.4 million were included in the accounts receivable balance as of December 31, 2024 and 2023, respectively.
Deferred Implementation Costs
The Company capitalizes certain personnel and other costs, such as employee salaries, stock-based compensation, benefits and the associated payroll taxes that are identifiable and directly related to the implementation of its solutions. The Company analyzes implementation costs that may be capitalized to assess their recoverability and only capitalizes costs that it anticipates being recoverable through the terms of the associated contract. The Company begins amortizing the deferred implementation costs for an implementation to cost of revenues once the revenue recognition criteria have been met, and the Company amortizes those deferred implementation costs ratably over the expected period of customer benefit. The Company has determined this period to be the estimated life of the technology for new contracts, which is estimated to be five to seven years, or over the term of the agreement for contract renewals and customer expansions. The Company determined the period of benefit by considering factors such as historically high renewal rates with similar customers and contracts, initial contract length, an expectation that there will still be a demand for the product at the end of its term and the significant costs to switch to a competitor's product, all of which are governed by the estimated useful life of the technology. The Company monitors
deferred implementation costs for impairment and records impairment when customers terminate or allow services to lapse due to contract modifications and/or from other assessments as needed. Any impairment losses identified are recognized in the form of an expense acceleration with the applicable amount recorded to deferred implementation costs, current portion and/or deferred implementation costs, net of current portion on the consolidated balance sheet and in cost of revenues in the consolidated statements of comprehensive loss.
The portion of deferred implementation costs expected to be amortized during the succeeding twelve-month period is recorded in current assets as deferred implementation costs, current portion, and the remainder is recorded in long-term assets as deferred implementation costs, net of current portion on the consolidated balance sheets.
Deferred Solution and Other Costs
The Company capitalizes sales commissions and other third-party costs such as third-party licenses and maintenance related to its customer agreements. The Company capitalizes sales commissions because the commission payments are considered incremental and recoverable costs of obtaining a contract with a customer. The Company capitalizes commissions and related bonuses for those involved in the sale which are incremental to the sale and their associated management. Substantially all commissions are paid in a single payment once the contract has been executed. The Company begins amortizing deferred solution and other costs for a particular customer agreement once the revenue recognition criteria are met and amortizes those deferred costs over the expected period of customer benefit. The Company has determined this period to be the estimated life of the technology for new contracts, which is estimated to be five to seven years, or over the term of the agreement for contract renewals and customer expansions. The Company determined the period of benefit by considering factors such as historically high renewal rates with similar customers and contracts, initial contract length, an expectation that there will still be a demand for the product at the end of its term and the significant costs to switch to a competitor's product, all of which are governed by the estimated useful life of the technology. The Company monitors deferred solution and other costs for impairment and records impairment when customers terminate or allow services to lapse due to contract modifications and/or from other assessments as needed. Any impairment losses identified are recognized in the form of an expense acceleration with the applicable amount recorded to deferred solution and other costs, current portion and/or deferred solution and other costs, net of current portion on the consolidated balance sheet and in sales and marketing expenses in the consolidated statements of comprehensive loss.
The Company capitalizes solution and other costs that it anticipates being recoverable. The portion of capitalized costs expected to be amortized during the succeeding twelve-month period is recorded in current assets as deferred solution and other costs, current portion, and the remainder is recorded in long-term assets as deferred solution and other costs, net of current portion. Amortization expense related to sales commissions is included in sales and marketing expenses in the consolidated statements of comprehensive loss.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful lives of the related assets. Maintenance and repairs that do not extend the life of or improve an asset are expensed in the period incurred.
Purchase Price Allocation, Intangible Assets, and Goodwill
The purchase price allocation for business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the identifiable tangible and intangible assets acquired and liabilities assumed based on their respective fair values. The Company determines whether substantially all the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the single asset or group of assets, as applicable, is not a business. If it is not met, the Company determines whether the single asset or group of assets, as applicable, meets the definition of a business.
In connection with its business combinations, the Company recorded certain intangible assets, including acquired technology, customer relationships, trademarks, and non-compete agreements. Amounts allocated to the acquired intangible assets are amortized on a straight-line basis over the estimated useful lives. The Company periodically reviews the estimated useful lives and fair values of its identifiable intangible assets, taking into consideration any events or circumstances which might result in a diminished fair value or revised useful life.
The excess purchase price over the fair value of assets acquired is recorded as goodwill. The Company tests goodwill for impairment annually in October, or whenever events or changes in circumstances indicate an impairment may have occurred. Because the Company operates as a single reporting unit, the impairment test is performed at the consolidated entity level by comparing the estimated fair value of the Company to the carrying value of the Company. The Company estimates the fair value of the reporting unit using a "step one" analysis using a fair-value-based approach based on market capitalization to determine if it is more likely than not that the fair value of the reporting unit is less than its carrying amount. Determining the fair value of goodwill is subjective in nature and often involves the use of estimates and assumptions including, without limitation, use of estimates of future prices and volumes for the Company's products, capital needs, economic trends and other factors which are inherently difficult to forecast. If actual results, or the plans and estimates used in future impairment analyses are lower than the original estimates used to assess the recoverability of these assets, the Company could incur impairment charges in a future period.
Software Development Costs
During the application development stage, the Company capitalizes certain development costs associated with internal use software and the Company's SaaS platform. Software development costs include salaries and other personnel-related costs for those employees who are directly associated with and who devote time to developing the Company's software solutions, including employee benefits, stock-based compensation and bonuses attributed to software engineers, quality control teams and third-party development costs. Capitalized software development costs are computed on an individual product basis. The Company also capitalizes certain costs related to specific enhancements when it is probable the expenditures will result in additional features and functionality. Capitalization ceases for products and enhancements when released or made available. Software development costs for internal-use software are amortized to cost of revenues when products and enhancements are released or made available over the products' estimated economic lives, which are expected to be five years. The costs related to software development are included in intangible assets, net on the consolidated balance sheets. Costs incurred in the preliminary stages of development and maintenance costs are expensed as incurred.
Research and Development Costs
Research and development expenses include salaries and personnel-related costs, including employee benefits, bonuses and stock-based compensation, third-party contractor expenses, software development costs, allocated overhead and other related expenses incurred in developing new solutions and enhancing existing solutions.
Certain research and development costs that are related to the Company's software development, which include salaries and other personnel-related costs, comprised of employee benefits, stock-based compensation and bonuses attributed to programmers, software engineers and quality control teams working on the Company's software solutions, are capitalized and included in intangible assets, net on the consolidated balance sheets.
Advertising Advertising costs of the Company are generally expensed the first time the advertising takes place.The Company entered into a long-term stadium sponsorship agreement in 2020, and beginning in the second quarter of 2021, payments under this arrangement are deferred and expensed as advertising costs on a straight-line basis over the term of the arrangement.
Sales Tax
The Company presents sales taxes and other taxes collected from customers and remitted to governmental authorities on a net basis and, as such, excludes them from revenues.
Comprehensive Loss
Comprehensive loss includes net loss as well as other changes in stockholders' equity that result from transactions and economic events other than those with stockholders. Other comprehensive loss consists of net loss, unrealized gains and losses on available-for-sale investments, and foreign currency translation adjustments.
Stock-Based Compensation
Stock-based compensation consists of restricted stock units, or RSUs, performance-based restricted stock units, and purchase rights under our employee stock purchase plan, or ESPP, and is used to compensate employees, directors and consultants. All awards are measured at fair value on grant date and forfeitures are recognized as they occur.
The Company values RSUs at the closing market price on the date of grant. RSUs typically vest in equal installments over a four-year period and compensation expense is recognized straight-line over the requisite service period.
The Company values purchase rights under the ESPP using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires inputs including the risk-free interest rate, expected term and expected volatility and the Company assumes no dividend yield. The Company's ESPP has two six-month offering periods which commence on each June 1 and December 1. The Company recognizes compensation expense straight-line over the withholding period for the ESPP.
The Company grants performance-based restricted stock units which provide for shares of common stock to be earned based on its total stockholder return, or TSR, performance relative to the TSR performance of specified stock indexes, or TSR PSUs, and previously referred to as Market Stock Units, or MSUs. The Company values TSR PSUs and MSUs on grant date using the Monte Carlo simulation model. The determination of fair value is affected by the Company's stock price and a number of assumptions including the expected volatility and the risk-free interest rate. The Company's expected volatility at the date of grant is based on the historical volatilities of its stock and peer firms' stocks and the Index over the performance period. The Company assumes no dividend yield and recognizes compensation expense ratably over the performance period of the award, as applicable. The number of TSR PSUs and MSUs that vest is based on actual TSR relative to the TSR benchmark as set forth in the award agreement. The minimum percentage that can vest is 0%, with a maximum percentage of 200%. TSR PSUs and MSUs will vest over two-year and three-year performance periods. The Company recognizes compensation expense using the graded attribution method on a straight-line basis over the performance period for each award, as applicable.
The Company also grants performance-based restricted stock units which provide for shares of common stock to be earned based on its attainment of Adjusted EBITDA as a percentage of non-GAAP Revenue relative to a target specified in the applicable agreement, or EBITDA PSUs. The Company values EBITDA PSUs at the closing market price on the date of grant. The minimum percentage of EBITDA PSUs that can vest is 0%, with a maximum percentage of 200%. The vesting of EBITDA PSUs is conditioned upon the achievement of certain internal targets and will vest over a two-year and three-year performance period. The Company recognizes compensation expense using the accelerated attribution method over the performance period, if it is probable that the performance condition will be achieved. Adjustments to compensation expense are made each reporting period based on changes in our estimate of the number of EBITDA PSUs that are probable of vesting.
Convertible Senior Notes
The Company accounts for its convertible notes as a liability at face value less unamortized debt issuance costs. Debt issuance costs are amortized to interest expense over the respective term of its convertible notes on a straight-line basis, which approximates the effective interest method.
Leases
The Company determines if a contract contains a lease for accounting purposes at the inception of the arrangement. The Company has elected to apply the practical expedient which allows the Company to account for lease and non-lease components of a contract as a single leasing arrangement. In addition, the Company has elected the practical expedients related to lease classification and the short-term lease exemption, whereby leases with initial terms of one year or less are not capitalized and instead expensed generally on a straight-line basis over the lease term. The Company is primarily a lessee with a lease portfolio comprised mainly of real estate and equipment leases. As of December 31, 2024, the Company had no finance leases.
Operating lease assets are included on the Company's consolidated balance sheets in non-current assets as a right of use asset and represent the Company's right to use an underlying asset for the lease term. Operating lease liabilities are included on the Company's consolidated balance sheets in lease liabilities, current portion, for the portion that is due within 12 months and in lease liabilities, net of current portion, for the portion that is due beyond 12 months of the financial statement date and represent the Company's obligation to make lease payments.
Right of use assets and lease liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term using an appropriate discount rate. If an implicit rate is not readily determined by the Company's leases, the Company utilizes the incremental borrowing rate based on the available information at the commencement date to determine the present value of lease payments. The depreciable lives of the underlying leased assets are generally limited to the expected lease term inclusive of any optional lease renewals where the Company concludes at the inception of the lease that the Company is reasonably certain of exercising those options. The right of use asset calculation may
also include any initial direct costs paid and is reduced by any lease incentives provided by the lessor. Lease expense for lease payments is recognized on a straight-line basis over the lease term, except for impaired leases for which the lease expense is recognized on a declining basis over the remaining lease term.
Impairment of Long-Lived Assets
Impairment of long-lived assets such as property and equipment, acquired intangible assets, capitalized software development costs and right of use assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The Company evaluates the recoverability of its long-lived assets by comparing the carrying amount of the asset group to the estimated undiscounted future cash flows. If the carrying value is not recoverable, an impairment is recognized to the extent that the carrying value of the asset group exceeds its fair value.
Income Taxes
Deferred income taxes are provided for the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their respective tax bases and operating loss carryforwards and credits using enacted tax rates expected to be in effect in the years in which the differences are expected to reverse. The Company assesses the likelihood that deferred tax assets will be realized and recognizes a valuation allowance if it is more likely than not that some portion of the deferred tax assets will not be realized. This assessment requires judgment as to the likelihood and amounts of future taxable income by tax jurisdiction. To date, the Company has provided a valuation allowance against most of its deferred tax assets as it believes the objective and verifiable evidence of its historical pretax net losses outweighs any positive evidence of its forecasted future results. The Company will continue to monitor the positive and negative evidence, and it will adjust the valuation allowance as sufficient objective positive evidence becomes available.
The Company evaluates its uncertain tax positions based on a determination of whether and how much of a tax benefit or expense taken by the Company in its tax filings or positions is more likely than not to be realized. The Company believes it has accrued adequate reserves related to its uncertain tax positions; however, ultimate determination of the Company's liability is subject to audit by taxing authorities in the ordinary course of business. The Company records interest and penalties associated with any uncertain tax positions as a component of income tax expense.
Recent Accounting Pronouncements
In November 2023, the Financial Accounting Standard Board, or FASB, issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which amends the disclosure to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an annual and interim basis to better understand the reporting entity's performance and prospects for future net cash flows and make more informed judgments. All public entities are required to report segment information in accordance with the new guidance starting in annual periods beginning after December 15, 2023. The Company adopted the standard during the year ended December 31, 2024. See Note 16 - Segments and Geographic Information for further detail.
In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvement to Income Tax Disclosures" which requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The ASU is effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its financial statement disclosures.
In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses" which requires public companies to disclose additional information about certain costs and expenses in the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027, on a prospective basis. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this standard will have on its financial statement disclosures.
Fair Value Measurement
The carrying values of the Company's financial assets not measured at fair value on a recurring basis, principally accounts receivable, restricted cash and accounts payable, approximated their fair values due to the short period of time to maturity or repayment.
Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The current accounting guidance for fair value measurements defines a three-level valuation hierarchy for disclosures as follows:
Level I—Unadjusted quoted prices in active markets for identical assets or liabilities;
Level II—Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data; and
Level III—Unobservable inputs that are supported by little or no market activity, which requires the Company to develop its own assumptions.
The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
v3.25.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Schedule of Useful Lives of Property and Equipment
The estimated useful lives of property and equipment are as follows:
Computer hardware and equipment
3 - 5 years
Purchased software and licenses
3 - 5 years
Furniture and fixtures
7 years
Leasehold improvementsLesser of estimated useful life or lease term
Property and equipment consisted of the following:
 December 31,
 20242023
Computer hardware and equipment$70,390 $67,942 
Purchased software and licenses11,053 12,075 
Furniture and fixtures10,194 9,997 
Leasehold improvements30,496 28,217 
122,133 118,231 
Accumulated depreciation(90,605)(77,053)
Property and equipment, net$31,528 $41,178 
Schedule of Net Loss Per Share, Basic and Diluted
Year ended December 31,
 202420232022
Numerator: 
Net loss $(38,536)$(65,384)$(108,983)
Denominator: 
Weighted-average common shares outstanding, basic and diluted60,105 58,354 57,300 
Net loss per common share, basic and diluted$(0.64)$(1.12)$(1.90)
Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share The following table sets forth the anti-dilutive common share equivalents for the periods listed:
 Year ended December 31,
 202420232022
Stock options, restricted stock units, market stock units and performance stock units4,590 4,776 3,667 
Shares issuable pursuant to the ESPP68 102 85 
Shares related to convertible notes4,793 5,042 6,256 
9,451 9,920 10,008 
v3.25.0.1
Revenue (Tables)
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue by Major Source
The following table disaggregates the Company's revenue by major source:
 Year Ended December 31,
 202420232022
Subscription$553,610 $475,945 $412,040 
Transactional68,489 65,416 67,373 
Services and Other74,365 83,263 86,260 
Total Revenues$696,464 $624,624 $565,673 
Schedule of Allowance for Sales Credits
The following table shows the Company's allowance for sales credits, credit losses, and other reserved balances as follows:
Beginning BalanceAdditionsDeductionsEnding Balance
Year Ended December 31, 2022$2,761 $2,931 $(3,692)$2,000 
Year Ended December 31, 20232,000 1,214 (1,813)1,401 
Year Ended December 31, 2024$1,401 $1,196 $(1,254)$1,343 
v3.25.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets Measured on Recurring Basis
The following table details the fair value hierarchy of the Company's financial assets measured at fair value on a recurring basis as of December 31, 2024:
Fair Value Measurements Using:
AssetsFair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Cash Equivalents:
Money market funds$63,945 $63,945 $— $— 
Certificates of deposit245 — 245 — 
$64,190 $63,945 $245 $— 
Investments:Fair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Corporate bonds and commercial paper$46,702 $— $46,702 $— 
Certificates of deposit14,092 — 14,092 — 
U.S. government securities26,922 — 26,922 — 
$87,716 $— $87,716 $— 
The following table details the fair value hierarchy of the Company's financial assets measured at fair value on a recurring basis as of December 31, 2023:
Fair Value Measurements Using:
AssetsFair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Cash Equivalents:
Money market funds$86,611 $86,611 $— $— 
Investments:Fair ValueQuoted Prices
in Active
Markets for
Identical Assets
(Level I)
Significant Other
Observable Inputs
(Level II)
Significant
Unobservable
Inputs
(Level III)
Corporate bonds and commercial paper$31,852 $— $31,852 $— 
Certificates of deposit9,321 — 9,321 — 
U.S. government securities53,055 — 53,055 — 
$94,228 $— $94,228 $— 
v3.25.0.1
Cash, Cash Equivalents and Investments (Tables)
12 Months Ended
Dec. 31, 2024
Cash and Cash Equivalents [Abstract]  
Schedule of Cash, Cash Equivalents and Investments
A summary of the Company's cash equivalents and investments that are carried at fair value as of December 31, 2024 is as follows:
Cash Equivalents:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Money market funds$63,945 $— $— $63,945 
Certificates of deposit245 — — 245 
$64,190 $— $— $64,190 
Investments:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Corporate bonds and commercial paper$46,626 $104 $(28)$46,702 
Certificates of deposit14,076 20 (4)14,092 
U.S. government securities26,917 22 (17)$26,922 
$87,619 $146 $(49)$87,716 
A summary of the Company's cash equivalents and investments that are carried at fair value as of December 31, 2023 is as follows:
Cash Equivalents:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Money market funds$86,611 $— $— $86,611 
Investments:Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Corporate bonds and commercial paper$31,979 $$(130)$31,852 
Certificates of deposit9,337 — (16)9,321 
U.S. government securities53,208 — (153)53,055 
$94,524 $$(299)$94,228 
Schedule of Contractual Maturity
The following table summarizes the estimated fair value of the Company's debt investments, designated as available-for-sale and classified by the contractual maturity date of the investments as of the dates shown:
December 31,
 20242023
Due within one year or less$49,460 $87,133 
Due after one year through two years38,256 7,095 
$87,716 $94,228 
Schedule of Fair Values and Gross Unrealized Losses for Available-for-sale Securities
The following table presents the fair values and the gross unrealized losses of these available-for-sale debt investments as of December 31, 2024, aggregated by investment category and the length of time that individual securities have been in a continuous loss position:
Less than 12 months12 months or greater
 Fair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Corporate bonds and commercial paper$19,229 $(28)$— $— 
Certificates of deposit1,722 (4)248 — 
U.S. government securities9,882 (17)— — 
$30,833 $(49)$248 $— 
The following table presents the fair values and the gross unrealized losses of these available-for-sale debt investments as of December 31, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position:
Less than 12 months12 months or greater
Fair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
Corporate bonds and commercial paper$12,060 $(39)$18,525 $(91)
Certificates of deposit1,999 (5)2,215 (11)
U.S. government securities18,140 (42)32,421 (111)
$32,199 $(86)$53,161 $(213)
v3.25.0.1
Deferred Solution and Other Costs (Tables)
12 Months Ended
Dec. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Deferred Solution and Other Costs
Deferred solution and other costs, current portion and net of current portion, consisted of the following:
 December 31,
 20242023
Deferred solution costs$16,741 $18,527 
Deferred commissions9,870 8,994 
Deferred solution and other costs, current portion$26,611 $27,521 
Deferred solution costs$2,628 $4,476 
Deferred commissions25,488 21,614 
Deferred solution and other costs, net of current portion$28,116 $26,090 
v3.25.0.1
Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment
The estimated useful lives of property and equipment are as follows:
Computer hardware and equipment
3 - 5 years
Purchased software and licenses
3 - 5 years
Furniture and fixtures
7 years
Leasehold improvementsLesser of estimated useful life or lease term
Property and equipment consisted of the following:
 December 31,
 20242023
Computer hardware and equipment$70,390 $67,942 
Purchased software and licenses11,053 12,075 
Furniture and fixtures10,194 9,997 
Leasehold improvements30,496 28,217 
122,133 118,231 
Accumulated depreciation(90,605)(77,053)
Property and equipment, net$31,528 $41,178 
v3.25.0.1
Goodwill and Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets
Intangible assets at December 31, 2024 and 2023 were as follows:
As of December 31, 2024As of December 31, 2023
Gross AmountAccumulated AmortizationNet Carrying AmountGross AmountAccumulated AmortizationNet Carrying Amount
Customer relationships$1,495 $(1,401)$94 $55,540 $(46,065)$9,475 
Non-compete agreements— — — 12,020 (10,058)1,962 
Trademarks— — — 19,870 (14,266)5,604 
Acquired technology 150,097 (112,791)37,306 150,097 (90,776)59,321 
Capitalized software development costs81,080 (23,847)57,233 56,147 (10,937)45,210 
$232,672 $(138,039)$94,633 $293,674 $(172,102)$121,572 
Schedule of Useful Life
The estimated useful lives and weighted average remaining amortization periods for intangible assets at December 31, 2024 are as follows (in years):
Estimated Useful Life Weighted Average Remaining Amortization Period
Customer relationships40.3
Acquired technology
5 - 7
1.9
Capitalized software development costs53.8
Total3.1
Schedule of Estimated Future Amortization Expense
The estimated future amortization expense related to intangible assets as of December 31, 2024 was as follows:
Amortization
Year Ended December 31,
2025$37,359 
202630,791 
202714,855 
20288,586 
20293,042 
Total amortization$94,633 
v3.25.0.1
Accrued Liabilities (Tables)
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following:
 December 31,
 20242023
Accrued data center equipment, software and services$2,704 $1,922 
Accrued transaction processing fees5,904 5,183 
Accrued professional services2,748 2,405 
Lease and other restructuring charges1,868 2,428 
Other5,015 4,533 
Accrued liabilities$18,239 $16,471 
v3.25.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Operating Lease Cost, Lease Term and Discount Rate
The components of lease costs, lease term and discount rate as of December 31 were as follows:
Operating Leases
202420232022
Lease expense:
Operating lease expense$9,360 $9,257 $11,002 
Sublease income(949)(1,004)(1,308)
Total lease expense $8,411 $8,253 $9,694 
Other information:
Cash paid for operating lease liabilities$13,220 $12,678 $12,886 
Right of use assets obtained in exchange for operating lease liabilities for the years ended December 31, 2024, 2023 and 2022
$2,605 $3,292 $917 
Weighted-average remaining lease term - operating leases6.2 years6.6 years7.5 years
Weighted-average discount rate - operating leases6.0 %6.2 %5.2 %
Schedule of Operating Lease Liability Maturities
Maturities of the Company's operating lease liabilities for lease terms in excess of one year at December 31, 2024 were as follows:
Operating Leases
Year Ended December 31,
2025$12,500 
202610,217 
20278,915 
20285,782 
20294,276 
Thereafter15,712 
Total lease payments57,402 
Less: imputed interest(8,729)
Total operating lease liabilities$48,673 
v3.25.0.1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Future Minimum Contractual Commitments
Future minimum contractual commitments that have initial non-cancelable terms in excess of one year at December 31, 2024 were as follows:
Contractual Commitments
Year Ended December 31,
2025$265,876 
2026352,492 
202711,298 
20284,621 
2029219 
Total commitments$634,506 
v3.25.0.1
Debt (Tables)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Convertible Notes
The following table presents details of the Company's convertible senior notes outstanding as of December 31, 2024, which are further discussed below (principal in thousands):
Date Issued
Maturity Date (1)
Principal
Interest Rate per Annum
Conversion Rate for Each $1,000 Principal (2)
Initial Conversion Price per Share
2026 Notes
June 1, 2019
June 1, 2026
$303,995 0.75 %$11.2851 $88.61 
2025 NotesNovember 15, 2020November 15, 2025$191,000 0.125 %$7.1355 $140.14 
____________________________________________________________________________
(1) Unless earlier converted or repurchased in accordance with their terms prior to such date
(2) Subject to adjustment upon the occurrence of certain specified events
The Notes consist of the following:
As of December 31, 2024As of December 31, 2023
2026 Notes2025 Notes2026 Notes2025 Notes
Principal$303,995 $191,000 $303,995 $191,000 
Unamortized debt issuance costs(1,880)(669)(3,133)(1,398)
Net carrying amount$302,115 $190,331 $300,862 $189,602 
Schedule of Interest Expense
The following table sets forth expenses related to the Notes and Revolving Credit Agreement:
Year Ended December 31,
202420232022
Contractual interest expense$2,681 $2,532 $2,892 
Amortization of debt issuance costs2,059 2,104 2,719 
Total$4,740 $4,636 $5,611 
v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation Expense Recorded in the Consolidated Statements of Comprehensive Loss
Stock-based compensation expense was recorded in the following cost and expense categories on the Company's consolidated statements of comprehensive loss:
 Year Ended December 31,
 202420232022
Cost of revenues$11,821 $13,346 $12,262 
Sales and marketing16,779 16,771 15,379 
Research and development16,456 15,157 13,987 
General and administrative44,159 33,914 23,529 
Total stock-based compensation expense$89,215 $79,188 $65,157 
Schedule of Share-based Compensation, Stock Options, Activity
Stock option activity was as follows:
Number of
Options
Weighted Average
Exercise Price
Balance as of January 1, 2022363 $34.42 
Granted— — 
Exercised(27)26.06 
Forfeited— — 
Expired(12)35.80 
Balance as of December 31, 2022324 35.07 
Granted— — 
Exercised(74)30.91 
Forfeited— — 
Expired(4)27.86 
Balance as of December 31, 2023246 36.43 
Granted— — 
Exercised(234)35.90 
Forfeited— — 
Expired — — 
Balance as of December 31, 202412 $47.00 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
The summary of stock options outstanding as of December 31, 2024 is as follows:
 Options Outstanding and Exercisable
Exercise PricesNumber of
Options
Weighted Average
Exercise Price
Weighted Average
Remaining
Contractual Life
(in years)
$47.00
12 $47.00 0.2
Schedule of Restricted Stock Units Activity
Restricted stock unit activity was as follows:
Number of
Shares
Weighted Average
Grant Date Fair Value
Nonvested as of January 1, 20221,620 $90.75 
Granted2,186 45.62 
Vested(609)82.50 
Forfeited(253)78.70 
Nonvested as of December 31, 20222,944 59.99 
Granted1,981 32.31 
Vested(963)63.59 
Forfeited(366)48.39 
Nonvested as of December 31, 20233,596 44.96 
Granted1,513 49.30 
Vested(1,231)50.49 
Forfeited(361)45.45 
Nonvested as of December 31, 20243,517 $44.84 
Schedule of Market Stock Units and Performance Stock Units Activity
MSU and PSU activity was as follows:
Number of SharesWeighted Average Grant Date Fair Value
Nonvested as of January 1, 2022281 $59.74 
Granted239 46.75 
Vested— — 
Forfeited(121)41.71 
Nonvested as of December 31, 2022399 57.42 
Granted587 39.59 
Vested(4)23.21 
Forfeited(48)55.55 
Nonvested as of December 31, 2023934 46.45 
Granted389 59.92 
Change in awards based on performance(1)
11 88.40 
Vested(82)45.90 
Forfeited(191)59.12 
Nonvested as of December 31, 20241,061 $49.58 
________________________________________________________________________
(1)Represents the change in the number of MSUs earned based on performance achievement for the performance period.
Schedule of Share-based Payment Award Assumptions for Estimating Fair Value of Stock Option Grants
Significant assumptions used in the Monte Carlo simulation model for the TSR PSUs and MSUs granted during the year ended December 31, 2024, 2023, and 2022 are as follows:
Year Ended December 31,
202420232022
Volatility
53.5 - 54.1%
52.7% - 54.8%
45.4%
Risk-free interest rate
4.2 - 4.5%
3.9% - 4.5%
1.9%
Dividend yield
Longest remaining performance period (in years)333
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The following summarizes the assumptions used for estimating the fair value of ESPP purchase rights:
Year Ended December 31,
 202420232022
Risk-free interest rate
4.4 - 5.4%
5.3 - 5.4%
0.3% - 4.7%
Expected life (in years)
0.5
0.5
0.3 - 0.5
Expected volatility
38.4 - 40.8%
37.2 - 66.0%
49.7% - 65.6%
Dividend yield
Grant date fair value per share
$16.55 - $28.10
$9.71 - $9.87
$9.45 - $17.30
v3.25.0.1
Provision for Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of U.S. and Non-U.S. Components of Loss Before Income Taxes
The U.S. and non-U.S. components of loss before income taxes consisted of the following:
 December 31,
 20242023
U.S.$(38,615)$(64,164)
Non-U.S.7,755 2,342 
Loss before income taxes$(30,860)$(61,822)
Schedule of Components of Provision for Income Taxes
The components of the Company's provision for income taxes consisted of the following:
 Year Ended December 31,
 202420232022
Current taxes:   
Federal$— $— $— 
Foreign2,151 1,976 959 
State3,025 660 1,268 
Total current taxes$5,176 $2,636 $2,227 
Deferred taxes:   
Federal$1,427 $420 $420 
Foreign276 (251)(355)
State797 757 616 
Total deferred taxes2,500 926 681 
Provision for income taxes $7,676 $3,562 $2,908 
Schedule of Significant Components of Deferred Taxes Significant components of the Company's deferred taxes consisted of the following:
 December 31,
 20242023
Deferred tax assets:
NOL and credit carryforwards$116,084 $128,670 
Deferred revenue26,069 22,802 
Accrued expenses and other7,190 6,285 
Stock-based compensation11,080 11,425 
Lease liabilities11,633 13,600 
Interest expense carryforwards— 6,202 
Convertible debt hedge2,957 5,727 
IRC Section 174 expenditures73,860 56,711 
Total deferred tax assets248,873 251,422 
Deferred tax liabilities: 
Deferred expenses(17,858)(14,960)
Depreciation and amortization(11,441)(17,491)
Capitalized software(1,690)(1,694)
Right of use assets(7,166)(8,497)
Total deferred tax liabilities(38,155)(42,642)
Deferred tax assets less tax liabilities210,718 208,780 
Less: valuation allowance(217,053)(212,614)
Net deferred tax liability$(6,335)$(3,834)
Schedule of Effective Income Tax Rate Reconciliation
The Company's provision for income taxes attributable to continuing operations differs from the expected tax benefit amount computed by applying the statutory federal income tax rate of 21% to income before taxes for each of the years ended December 31, 2024, 2023, and 2022, respectively, primarily as a result of the following:
 Year Ended December 31,
 202420232022
Income tax at U.S. statutory rate21.0 %21.0 %21.0 %
Effect of: 
Increase in deferred tax valuation allowance(26.4)(0.7)(14.8)
Stock compensation(0.2)(12.4)(4.8)
Acquisitions— — (0.2)
R&D credit— — (2.4)
State taxes, net of federal benefit1.3 4.5 0.6 
Change in uncertain tax positions(1.2)0.4 1.5 
Executive compensation(13.5)(4.8)(1.8)
GILTI inclusion(2.0)— (1.6)
Foreign NOL write-off— (14.5)— 
Federal return to provision— 2.7 — 
Other permanent items(2.0)(2.0)(0.2)
Income tax provision effective rate(23.1)%(5.8)%(2.7)%
Schedule of Unrecognized Tax Benefits The reconciliation of uncertain tax positions at the beginning and end of the year is as follows:
Year Ended December 31,
20242023
Beginning balance$720 $977 
Gross increase (decrease) related to prior year positions38 (510)
Gross increase related to current year positions338 253 
Ending balance$1,096 $720 
v3.25.0.1
Organization and Description of Business (Details)
Dec. 31, 2024
Q2 Software, Inc.  
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]  
Wholly owned subsidiary, ownership percentage (in percent) 100.00%
v3.25.0.1
Summary of Significant Accounting Policies - Accounts Receivable (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Accounting Policies [Abstract]    
Unbilled receivables $ 7.7 $ 7.4
v3.25.0.1
Summary of Significant Accounting Policies - Deferred Implementation Costs, Deferred Solution and Other Costs (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Deferred Implementation Costs      
Capitalized Contract Cost [Line Items]      
Amortization of capitalized implementation costs $ 14.0 $ 13.4 $ 11.5
Deferred Commissions      
Capitalized Contract Cost [Line Items]      
Amortization of capitalized implementation costs $ 13.0 $ 12.5 $ 11.7
Minimum | Deferred Implementation Costs      
Capitalized Contract Cost [Line Items]      
Expected period of customer benefit (in years) 5 years    
Minimum | Deferred Commissions      
Capitalized Contract Cost [Line Items]      
Expected period of customer benefit (in years) 5 years    
Maximum | Deferred Implementation Costs      
Capitalized Contract Cost [Line Items]      
Expected period of customer benefit (in years) 7 years    
Maximum | Deferred Commissions      
Capitalized Contract Cost [Line Items]      
Expected period of customer benefit (in years) 7 years    
v3.25.0.1
Summary of Significant Accounting Policies - Schedule of Useful Lives of Property and Equipment (Details)
Dec. 31, 2024
Computer hardware and equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 3 years
Computer hardware and equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 5 years
Purchased software and licenses | Minimum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 3 years
Purchased software and licenses | Maximum  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 5 years
Furniture and fixtures  
Property, Plant and Equipment [Line Items]  
Estimated useful life (in years) 7 years
v3.25.0.1
Summary of Significant Accounting Policies - Software Development Costs (Details)
Dec. 31, 2024
Purchased software and licenses  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful life (in years) 5 years
v3.25.0.1
Summary of Significant Accounting Policies - Advertising (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accounting Policies [Abstract]      
Advertising costs $ 4.3 $ 4.3 $ 4.4
v3.25.0.1
Summary of Significant Accounting Policies - Stock-Based Compensation (Details) - offeringPeriod
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 4 years    
Shares issuable pursuant to the ESPP | Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected dividend rate 0.00%    
Number of offering periods during the year 2    
Award offering period 6 months    
TSR PSUs and MSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected dividend rate 0.00% 0.00% 0.00%
Minimum | TSR PSUs and MSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 2 years    
Award vesting rights 0.00%    
Minimum | Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 2 years    
Award vesting rights 0.00%    
Maximum | TSR PSUs and MSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
Award vesting rights 200.00%    
Maximum | Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period (in years) 3 years    
Award vesting rights 200.00%    
v3.25.0.1
Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Loss per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Numerator:      
Net loss $ (38,536) $ (65,384) $ (108,983)
Denominator:      
Weighted-average common shares outstanding, basic (in shares) 60,105 58,354 57,300
Weighted-average common shares outstanding, diluted (in shares) 60,105 58,354 57,300
Net loss per common share, basic (in usd per share) $ (0.64) $ (1.12) $ (1.90)
Net loss per common share, diluted (in usd per share) $ (0.64) $ (1.12) $ (1.90)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 9,451 9,920 10,008
Stock options, restricted stock units, market stock units and performance stock units      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 4,590 4,776 3,667
Shares issuable pursuant to the ESPP      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 68 102 85
Shares related to convertible notes      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Antidilutive securities excluded from computation of earnings per share (in shares) 4,793 5,042 6,256
v3.25.0.1
Revenue - Schedule of Disaggregation of Revenue by Major Source (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]      
Revenues $ 696,464 $ 624,624 $ 565,673
Subscription      
Disaggregation of Revenue [Line Items]      
Revenues 553,610 475,945 412,040
Transactional      
Disaggregation of Revenue [Line Items]      
Revenues 68,489 65,416 67,373
Services and Other      
Disaggregation of Revenue [Line Items]      
Revenues $ 74,365 $ 83,263 $ 86,260
v3.25.0.1
Revenue - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]    
Increase in contract assets from current year invoices, advanced cash payments $ 724,100,000  
Increase from netting of contract assets and liabilities on contract by contract basis 1,300,000  
Decrease from revenue recognized from current year invoices 577,800,000  
Revenue recognized that was included in the deferred revenue balance in prior year 118,700,000  
Revenue from remaining performance obligations 2,220,000,000  
Provision for expected credit losses, contract balances 0 $ 0
Writeoffs, contract balances 0 0
Reversal due to reduction in contract assets (prior year less than)   100,000
Allowance for credit losses related to contract assets 20,000.00 30,000.00
Accounts receivable, credit loss expense (reversal) 0 100,000
Accounts receivable, allowance for credit loss, writeoff 100,000 300,000
Allowance decrease (less than) (50,000.00)  
Allowance reserve 300,000 500,000
Sales Credits And Specific Reserves    
Disaggregation of Revenue [Line Items]    
Allowance reserve $ 1,000,000.0 $ 900,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01    
Disaggregation of Revenue [Line Items]    
Remaining performance obligation, percentage 52.00%  
Performance obligations expected to be satisfied, expected timing 24 months  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01    
Disaggregation of Revenue [Line Items]    
Remaining performance obligation, percentage 34.00%  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | Minimum    
Disaggregation of Revenue [Line Items]    
Performance obligations expected to be satisfied, expected timing 25 months  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01 | Maximum    
Disaggregation of Revenue [Line Items]    
Performance obligations expected to be satisfied, expected timing 48 months  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01 | Maximum    
Disaggregation of Revenue [Line Items]    
Performance obligations expected to be satisfied, expected timing  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01    
Disaggregation of Revenue [Line Items]    
Performance obligations expected to be satisfied, expected timing  
v3.25.0.1
Revenue - Schedule of Allowance for Sales Credits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]      
Beginning Balance $ 1,401 $ 2,000  
Additions 1,196 1,214 $ 2,931
Deductions (1,254) (1,813) (3,692)
Ending Balance $ 1,343 $ 1,401 2,000
SEC Schedule, 12-09, Allowance, Sales Credits, Credit Loss And Other      
Accounts Receivable, Allowance for Credit Loss [Roll Forward]      
Beginning Balance     $ 2,761
v3.25.0.1
Fair Value Measurements (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value $ 64,190  
Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 63,945 $ 86,611
Certificates of deposit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 245  
Fair Value, Measurements, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 64,190  
Investments at fair value 87,716 94,228
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level I)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 63,945  
Investments at fair value 0 0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level II)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 245  
Investments at fair value 87,716 94,228
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level III)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 0  
Investments at fair value 0 0
Fair Value, Measurements, Recurring | Corporate bonds and commercial paper    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 46,702 31,852
Fair Value, Measurements, Recurring | Corporate bonds and commercial paper | Quoted Prices in Active Markets for Identical Assets (Level I)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 0 0
Fair Value, Measurements, Recurring | Corporate bonds and commercial paper | Significant Other Observable Inputs (Level II)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 46,702 31,852
Fair Value, Measurements, Recurring | Corporate bonds and commercial paper | Significant Unobservable Inputs (Level III)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 0 0
Fair Value, Measurements, Recurring | Certificates of deposit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 14,092 9,321
Fair Value, Measurements, Recurring | Certificates of deposit | Quoted Prices in Active Markets for Identical Assets (Level I)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 0 0
Fair Value, Measurements, Recurring | Certificates of deposit | Significant Other Observable Inputs (Level II)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 14,092 9,321
Fair Value, Measurements, Recurring | Certificates of deposit | Significant Unobservable Inputs (Level III)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 0 0
Fair Value, Measurements, Recurring | U.S. government securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 26,922 53,055
Fair Value, Measurements, Recurring | U.S. government securities | Quoted Prices in Active Markets for Identical Assets (Level I)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 0 0
Fair Value, Measurements, Recurring | U.S. government securities | Significant Other Observable Inputs (Level II)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 26,922 53,055
Fair Value, Measurements, Recurring | U.S. government securities | Significant Unobservable Inputs (Level III)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments at fair value 0 0
Fair Value, Measurements, Recurring | Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 63,945 86,611
Fair Value, Measurements, Recurring | Money market funds | Quoted Prices in Active Markets for Identical Assets (Level I)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 63,945 86,611
Fair Value, Measurements, Recurring | Money market funds | Significant Other Observable Inputs (Level II)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 0 0
Fair Value, Measurements, Recurring | Money market funds | Significant Unobservable Inputs (Level III)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 0 $ 0
Fair Value, Measurements, Recurring | Certificates of deposit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 245  
Fair Value, Measurements, Recurring | Certificates of deposit | Quoted Prices in Active Markets for Identical Assets (Level I)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 0  
Fair Value, Measurements, Recurring | Certificates of deposit | Significant Other Observable Inputs (Level II)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value 245  
Fair Value, Measurements, Recurring | Certificates of deposit | Significant Unobservable Inputs (Level III)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents at fair value $ 0  
v3.25.0.1
Cash, Cash Equivalents and Investments - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]    
Impairment for credit losses $ 0 $ 0
Equity method investment other-than-temporary impairment 0 100,000
Equity method investments 300,000 100,000
Cash and cash equivalents 358,560,000 229,655,000
Available-for-sale debt securities allowance 0 0
Cash    
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 294,400,000 $ 143,000,000.0
v3.25.0.1
Cash, Cash Equivalents and Investments - Schedule of Cash, Cash Equivalents and Investments (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]    
Cash equivalents, amortized cost $ 64,190  
Investments, amortized cost 87,619 $ 94,524
Gross Unrealized Gains 146 3
Gross Unrealized Losses (49) (299)
Cash equivalents, fair value 64,190  
Investments, fair value 87,716 94,228
Corporate bonds and commercial paper    
Cash and Cash Equivalents [Line Items]    
Investments, amortized cost 46,626 31,979
Gross Unrealized Gains 104 3
Gross Unrealized Losses (28) (130)
Investments, fair value 46,702 31,852
Certificates of deposit    
Cash and Cash Equivalents [Line Items]    
Investments, amortized cost 14,076 9,337
Gross Unrealized Gains 20 0
Gross Unrealized Losses (4) (16)
Investments, fair value 14,092 9,321
U.S. government securities    
Cash and Cash Equivalents [Line Items]    
Investments, amortized cost 26,917 53,208
Gross Unrealized Gains 22 0
Gross Unrealized Losses (17) (153)
Investments, fair value 26,922 53,055
Money market funds    
Cash and Cash Equivalents [Line Items]    
Cash equivalents, amortized cost 63,945 86,611
Cash equivalents, fair value 63,945 $ 86,611
Certificates of deposit    
Cash and Cash Equivalents [Line Items]    
Cash equivalents, amortized cost 245  
Cash equivalents, fair value $ 245  
v3.25.0.1
Cash, Cash Equivalents and Investments - Schedule of Contractual Maturity (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Abstract]    
Due within one year or less $ 49,460 $ 87,133
Due after one year through two years 38,256 7,095
Total fair value $ 87,716 $ 94,228
v3.25.0.1
Cash, Cash Equivalents and Investments - Schedule of Fair Values and Gross Unrealized Losses for Available-for-sale Securities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]    
Debt securities, available-for-sale, less than 12 months, fair value $ 30,833 $ 32,199
Debt securities, available-for-sale, less than 12 months, gross unrealized losses (49) (86)
Debt securities, available-for-sale, 12 months or greater, fair value 248 53,161
Debt securities, available-for-sale, 12 months or greater, gross unrealized Loss 0 (213)
Corporate bonds and commercial paper    
Cash and Cash Equivalents [Line Items]    
Debt securities, available-for-sale, less than 12 months, fair value 19,229 12,060
Debt securities, available-for-sale, less than 12 months, gross unrealized losses (28) (39)
Debt securities, available-for-sale, 12 months or greater, fair value 0 18,525
Debt securities, available-for-sale, 12 months or greater, gross unrealized Loss 0 (91)
Certificates of deposit    
Cash and Cash Equivalents [Line Items]    
Debt securities, available-for-sale, less than 12 months, fair value 1,722 1,999
Debt securities, available-for-sale, less than 12 months, gross unrealized losses (4) (5)
Debt securities, available-for-sale, 12 months or greater, fair value 248 2,215
Debt securities, available-for-sale, 12 months or greater, gross unrealized Loss 0 (11)
U.S. government securities    
Cash and Cash Equivalents [Line Items]    
Debt securities, available-for-sale, less than 12 months, fair value 9,882 18,140
Debt securities, available-for-sale, less than 12 months, gross unrealized losses (17) (42)
Debt securities, available-for-sale, 12 months or greater, fair value 0 32,421
Debt securities, available-for-sale, 12 months or greater, gross unrealized Loss $ 0 $ (111)
v3.25.0.1
Deferred Solution and Other Costs (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Deferred solution costs $ 16,741 $ 18,527
Deferred commissions 9,870 8,994
Deferred solution and other costs, current portion 26,611 27,521
Deferred solution costs 2,628 4,476
Deferred commissions 25,488 21,614
Deferred solution and other costs, net of current portion $ 28,116 $ 26,090
v3.25.0.1
Property and Equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 122,133 $ 118,231  
Accumulated depreciation (90,605) (77,053)  
Property and equipment, net 31,528 41,178  
Depreciation 16,600 19,900 $ 17,700
Computer hardware and equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 70,390 67,942  
Purchased software and licenses      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 11,053 12,075  
Furniture and fixtures      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 10,194 9,997  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 30,496 $ 28,217  
v3.25.0.1
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]      
Goodwill $ 512,869,000 $ 512,869,000  
Impairment of goodwill 0    
Accumulated goodwill impairment 0    
Amortization of intangible assets 16,979,000 20,667,000 $ 18,248,000
Cost of revenues      
Finite-Lived Intangible Assets [Line Items]      
Amortization of intangible assets 35,200,000 31,100,000 25,700,000
Operating expense      
Finite-Lived Intangible Assets [Line Items]      
Amortization of intangible assets $ 17,000,000.0 $ 20,700,000 $ 18,200,000
Minimum      
Finite-Lived Intangible Assets [Line Items]      
Estimated useful life (in years) 4 years    
Maximum      
Finite-Lived Intangible Assets [Line Items]      
Estimated useful life (in years) 7 years    
v3.25.0.1
Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Gross Amount $ 232,672 $ 293,674
Accumulated Amortization (138,039) (172,102)
Net Carrying Amount 94,633 121,572
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 1,495 55,540
Accumulated Amortization (1,401) (46,065)
Net Carrying Amount 94 9,475
Non-compete agreements    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 0 12,020
Accumulated Amortization 0 (10,058)
Net Carrying Amount 0 1,962
Trademarks    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 0 19,870
Accumulated Amortization 0 (14,266)
Net Carrying Amount 0 5,604
Acquired technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 150,097 150,097
Accumulated Amortization (112,791) (90,776)
Net Carrying Amount 37,306 59,321
Capitalized software development costs    
Finite-Lived Intangible Assets [Line Items]    
Gross Amount 81,080 56,147
Accumulated Amortization (23,847) (10,937)
Net Carrying Amount $ 57,233 $ 45,210
v3.25.0.1
Goodwill and Intangible Assets - Schedule of Useful Life (Details)
12 Months Ended
Dec. 31, 2024
Acquired Finite-Lived Intangible Assets [Line Items]  
Weighted Average Remaining Amortization Period 3 years 1 month 6 days
Customer relationships  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated useful life (in years) 4 years
Weighted Average Remaining Amortization Period 3 months 18 days
Acquired technology  
Acquired Finite-Lived Intangible Assets [Line Items]  
Weighted Average Remaining Amortization Period 1 year 10 months 24 days
Capitalized software development costs  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated useful life (in years) 5 years
Weighted Average Remaining Amortization Period 3 years 9 months 18 days
Minimum  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated useful life (in years) 4 years
Minimum | Acquired technology  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated useful life (in years) 5 years
Maximum  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated useful life (in years) 7 years
Maximum | Acquired technology  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated useful life (in years) 7 years
v3.25.0.1
Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
2025 $ 37,359  
2026 30,791  
2027 14,855  
2028 8,586  
2029 3,042  
Net Carrying Amount $ 94,633 $ 121,572
v3.25.0.1
Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accrued data center equipment, software and services $ 2,704 $ 1,922
Accrued transaction processing fees 5,904 5,183
Accrued professional services 2,748 2,405
Lease and other restructuring charges 1,868 2,428
Other 5,015 4,533
Accrued liabilities $ 18,239 $ 16,471
v3.25.0.1
Leases - Narrative (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
building
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Lessee, Lease, Description [Line Items]      
Number of buildings occupied | building 2    
Rent expense $ 5,700 $ 5,300 $ 7,300
Total operating lease liabilities 48,673    
Right of use assets 30,402 35,453  
Operating lease, impairment loss $ 1,669 4,075 $ 11,669
Lease One      
Lessee, Lease, Description [Line Items]      
Lease renewal term (in years) 10 years    
Lease Two | Minimum      
Lessee, Lease, Description [Line Items]      
Lease renewal term (in years) 5 years    
Lease Two | Maximum      
Lessee, Lease, Description [Line Items]      
Lease renewal term (in years) 10 years    
Lease term (in years) 10 years    
Leases One And Two      
Lessee, Lease, Description [Line Items]      
Lease renewal reasonably certain, number of buildings | building 2    
Lease renewal reasonably certain, liability $ 15,300    
Total operating lease liabilities 10,900    
Right of use assets 8,100    
Lease Exit And Sublease | Right of Use Asset      
Lessee, Lease, Description [Line Items]      
Operating lease, impairment loss 800 1,900  
Lease Exit And Sublease | Property, Plant and Equipment      
Lessee, Lease, Description [Line Items]      
Operating lease, impairment loss $ 100 200  
Lease Exit And Sublease | Accrued Liabilities and Other Liabilities Noncurrent      
Lessee, Lease, Description [Line Items]      
Operating lease, impairment loss   $ 300  
v3.25.0.1
Leases - Schedule of Operating Lease Cost, Lease Term and Discount Rate (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Lease expense:      
Operating lease expense $ 9,360 $ 9,257 $ 11,002
Sublease income (949) (1,004) (1,308)
Total lease expense 8,411 8,253 9,694
Other information:      
Cash paid for operating lease liabilities 13,220 12,678 12,886
Right of use assets obtained in exchange for operating lease liabilities for the years ended December 31, 2024, 2023 and 2022 $ 2,605 $ 3,292 $ 917
Weighted-average remaining lease term - operating leases (in years) 6 years 2 months 12 days 6 years 7 months 6 days 7 years 6 months
Weighted-average discount rate - operating leases 6.00% 6.20% 5.20%
v3.25.0.1
Leases - Schedule of Operating Lease Liability Maturities (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Operating Lease Liabilities, Payments Due [Abstract]  
2025 $ 12,500
2026 10,217
2027 8,915
2028 5,782
2029 4,276
Thereafter 15,712
Total lease payments 57,402
Less: imputed interest (8,729)
Total operating lease liabilities $ 48,673
v3.25.0.1
Commitments and Contingencies - Schedule of Future Minimum Contractual Commitments (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2025 $ 265,876
2026 352,492
2027 11,298
2028 4,621
2029 219
Total commitments $ 634,506
v3.25.0.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]      
Gain contingencies recognized     $ 0.7
Restructuring payment period after departure   18 months  
Payments for restructuring $ 1.0    
Restructuring reserve $ 0.9    
v3.25.0.1
Debt - Schedule of Convertible Senior Notes (Details) - Convertible Debt
Nov. 15, 2020
USD ($)
$ / shares
Jun. 01, 2019
USD ($)
$ / shares
Nov. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Convertible Senior Notes Due June 2026        
Debt Instrument [Line Items]        
Principal | $   $ 303,995,000   $ 316,300,000
Interest Rate per Annum   0.75%    
Initial conversion rate of common stock   0.0112851    
Conversion price (in usd per share) | $ / shares   $ 88.61    
Convertible Notes Due November 2025        
Debt Instrument [Line Items]        
Principal | $ $ 191,000,000   $ 350,000,000  
Interest Rate per Annum 0.125%      
Initial conversion rate of common stock 0.0071355      
Conversion price (in usd per share) | $ / shares $ 140.14      
v3.25.0.1
Debt - Narrative (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
Nov. 30, 2020
USD ($)
day
Jun. 30, 2019
USD ($)
day
Mar. 31, 2022
Mar. 31, 2021
day
Sep. 30, 2020
Sep. 30, 2019
day
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Nov. 15, 2020
USD ($)
Jun. 01, 2019
USD ($)
Debt Instrument [Line Items]                        
Payment for repurchases of convertible notes               $ 0 $ 149,640,000 $ 0    
Gain on extinguishment of debt               0 19,869,000 $ 0    
Convertible Senior Notes Due June 2026 | Convertible Debt                        
Debt Instrument [Line Items]                        
Principal     $ 316,300,000                 $ 303,995,000
Repurchased principal amount $ 12,300,000                      
Payment for repurchases of convertible notes 10,700,000                      
Unamortized debt issuance costs               1,880,000 3,133,000      
Threshold percentage of stock price trigger     130.00%                  
Limitation on sale of common stock, sale price threshold, number of trading days | day     20                  
Limitation on sale of common stock, sale price threshold, trading period | day     30                  
Redemption price percentage     100.00%                  
If-converted value in excess of principal               39,200,000        
Convertible Senior Notes Due June 2026 | Convertible Debt | Debt Instrument, Redemption, Period One                        
Debt Instrument [Line Items]                        
Threshold percentage of stock price trigger             130.00%          
Limitation on sale of common stock, sale price threshold, number of trading days | day             20          
Limitation on sale of common stock, sale price threshold, trading period | day             30          
Convertible Senior Notes Due June 2026 | Convertible Debt | Debt Instrument, Redemption, Period Two                        
Debt Instrument [Line Items]                        
Limitation on sale of common stock, sale price threshold, number of trading days | day             5          
Limitation on sale of common stock, sale price threshold, trading period | day             5          
Percentage of closing sale price in excess of convertible notes           98.00%            
Convertible Notes Due November 2025 | Convertible Debt                        
Debt Instrument [Line Items]                        
Principal   $ 350,000,000                 $ 191,000,000  
Repurchased principal amount 159,000,000                      
Payment for repurchases of convertible notes 138,400,000                      
Unamortized debt issuance costs               $ 669,000 $ 1,398,000      
Threshold percentage of stock price trigger   130.00%                    
Limitation on sale of common stock, sale price threshold, number of trading days | day   20                    
Limitation on sale of common stock, sale price threshold, trading period | day   30                    
Redemption price percentage   100.00%                    
Convertible Notes Due November 2025 | Convertible Debt | Debt Instrument, Redemption, Period One                        
Debt Instrument [Line Items]                        
Threshold percentage of stock price trigger         130.00%              
Limitation on sale of common stock, sale price threshold, number of trading days | day         20              
Limitation on sale of common stock, sale price threshold, trading period | day         30              
Convertible Notes Due November 2025 | Convertible Debt | Debt Instrument, Redemption, Period Two                        
Debt Instrument [Line Items]                        
Limitation on sale of common stock, sale price threshold, number of trading days | day         5              
Limitation on sale of common stock, sale price threshold, trading period | day         5              
Percentage of closing sale price in excess of convertible notes       98.00%                
Convertible Senior Notes Due 2025 And 2026 | Convertible Debt                        
Debt Instrument [Line Items]                        
Gain on extinguishment of debt 19,900,000                      
Unamortized debt issuance costs $ 1,800,000                      
v3.25.0.1
Debt - Schedule of 2026 and 2025 Notes (Details) - Convertible Debt - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Convertible Senior Notes Due June 2026    
Debt Instrument [Line Items]    
Principal $ 303,995 $ 303,995
Unamortized debt issuance costs (1,880) (3,133)
Net carrying amount 302,115 300,862
Convertible Notes Due November 2025    
Debt Instrument [Line Items]    
Principal 191,000 191,000
Unamortized debt issuance costs (669) (1,398)
Net carrying amount $ 190,331 $ 189,602
v3.25.0.1
Debt - Capped Call Transactions (Details)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
Dec. 31, 2024
USD ($)
cappedCallTransaction
$ / shares
Debt Instrument [Line Items]    
Number of capped call transactions | cappedCallTransaction   2
Convertible Senior Notes Due June 2026 | Convertible Debt    
Debt Instrument [Line Items]    
Initial strike price (in usd per share)   $ 88.6124
Initial cap price (in usd per share)   $ 139.00
Cost incurred in connection with capped calls | $   $ 40.8
Convertible Notes Due November 2025 | Convertible Debt    
Debt Instrument [Line Items]    
Initial strike price (in usd per share)   $ 140.1443
Initial cap price (in usd per share)   $ 211.54
Cost incurred in connection with capped calls | $   $ 39.8
Convertible Senior Notes Due 2025 And 2026 | Convertible Debt    
Debt Instrument [Line Items]    
Proceeds received from capped call transaction settlement | $ $ 0.1  
v3.25.0.1
Debt - Revolving Credit Agreement and Interest Expense Narrative (Details) - USD ($)
12 Months Ended
Jul. 29, 2024
Dec. 31, 2024
Convertible Senior Notes Due June 2026    
Debt Instrument [Line Items]    
Debt instrument, convertible, remaining debt issuance costs amortization period   1 year 4 months 24 days
Convertible Notes Due November 2025    
Debt Instrument [Line Items]    
Debt instrument, convertible, remaining debt issuance costs amortization period   10 months 24 days
Revolving Credit Facility | Revolving Credit Agreement | Line of Credit    
Debt Instrument [Line Items]    
Line of credit facility term 5 years  
Line of credit facility, maximum borrowing capacity $ 125,000,000  
Unamortized debt issuance costs   $ 900,000
Long-term line of credit   $ 0
Revolving Credit Facility | Revolving Credit Agreement | Line of Credit | Minimum    
Debt Instrument [Line Items]    
Commitment fee percentage 0.15%  
Revolving Credit Facility | Revolving Credit Agreement | Line of Credit | Maximum    
Debt Instrument [Line Items]    
Commitment fee percentage 0.30%  
Revolving Credit Facility | Revolving Credit Agreement | Line of Credit | Base Rate | Minimum    
Debt Instrument [Line Items]    
Debt instrument, basis spread on variable rate 0.75%  
Revolving Credit Facility | Revolving Credit Agreement | Line of Credit | Base Rate | Maximum    
Debt Instrument [Line Items]    
Debt instrument, basis spread on variable rate 1.50%  
Revolving Credit Facility | Revolving Credit Agreement | Line of Credit | Secured Overnight Financing Rate (SOFR) | Minimum    
Debt Instrument [Line Items]    
Debt instrument, basis spread on variable rate 1.75%  
Revolving Credit Facility | Revolving Credit Agreement | Line of Credit | Secured Overnight Financing Rate (SOFR) | Maximum    
Debt Instrument [Line Items]    
Debt instrument, basis spread on variable rate 2.50%  
Bridge Loan | Revolving Credit Agreement | Line of Credit    
Debt Instrument [Line Items]    
Line of credit facility, maximum borrowing capacity $ 20,000,000  
Letter of Credit | Revolving Credit Agreement | Line of Credit    
Debt Instrument [Line Items]    
Line of credit facility, maximum borrowing capacity $ 10,000,000  
v3.25.0.1
Debt - Schedule of Interest Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]      
Amortization of debt issuance costs $ 2,059 $ 2,104 $ 2,719
Convertible Debt      
Debt Instrument [Line Items]      
Contractual interest expense 2,681 2,532 2,892
Amortization of debt issuance costs 2,059 2,104 2,719
Total $ 4,740 $ 4,636 $ 5,611
v3.25.0.1
Stock-Based Compensation - Narrative (Details) - USD ($)
12 Months Ended
Jan. 03, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Jun. 01, 2023
May 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation capitalized   $ 5,100,000 $ 5,300,000 $ 3,900,000    
Granted (in shares)   0 0 0    
Aggregate intrinsic value of options exercised in period   $ 1,500,000 $ 400,000 $ 600,000    
Aggregate intrinsic value of options outstanding   600,000        
Unrecognized stock-based compensation expense, related to stock options   0        
Restricted Stock Units (RSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation expense, vested   75,700,000 32,500,000 29,100,000    
Unrecognized stock-based compensation expense   $ 113,100,000        
Unrecognized stock-based compensation, period for recognition (in years)   2 years 4 months 24 days        
Employee Stock Purchase Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized stock-based compensation expense   $ 1,000,000        
Unrecognized stock-based compensation, period for recognition (in years)   4 months 24 days        
Number of shares purchased by the employees (in shares)   150,000        
Weighted-average fair value of the shares purchased (in USD per share)   $ 39.04        
Proceeds from stock plans   $ 5,900,000        
Market Stock Units and Performance Stock Units            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Stock-based compensation expense, vested   5,600,000 100,000 0    
Unrecognized stock-based compensation expense   $ 30,400,000        
Unrecognized stock-based compensation, period for recognition (in years)   1 year 8 months 12 days        
2014 Stock Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares reserved for future issuance under the plan (in shares)         7,606,000  
Total fair market value of stock options vested during the period   $ 0 $ 0 $ 10,000.00    
Employee Stock Purchase Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares reserved for future issuance under the plan (in shares)   1,224,000        
Purchase of common stock at discount from market price 15.00%          
Initial reserve of shares under the plan (in shares) 800,000          
Shares added to plan, automatic increase provision (in shares) 500,000          
Additional shares authorized under the plan, percentage increase 1.00%          
2023 Stock Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares reserved for future issuance under the plan (in shares)           14,045,000
Shares available for future issuance under the plan (in shares)   6,164,000        
v3.25.0.1
Stock-Based Compensation - Schedule of Share-based Compensation Expense Recorded in the Consolidated Statements of Comprehensive Loss (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense $ 89,215 $ 79,188 $ 65,157
Cost of revenues      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 11,821 13,346 12,262
Sales and marketing      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 16,779 16,771 15,379
Research and development      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense 16,456 15,157 13,987
General and administrative      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense $ 44,159 $ 33,914 $ 23,529
v3.25.0.1
Stock-Based Compensation - Schedule of Share-based Compensation, Stock Options, Activity (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Number of Options      
Beginning balance (in shares) 246,000 324,000 363,000
Granted (in shares) 0 0 0
Exercised (in shares) (234,000) (74,000) (27,000)
Forfeited (in shares) 0 0 0
Expired (in shares) 0 (4,000) (12,000)
Ending balance (in shares) 12,000 246,000 324,000
Weighted Average Exercise Price      
Options outstanding, beginning (in usd per share) $ 36.43 $ 35.07 $ 34.42
Granted (in usd per share) 0 0 0
Exercised (in usd per share) 35.90 30.91 26.06
Forfeited (in usd per share) 0 0 0
Expired (in usd per share) 0 27.86 35.80
Options outstanding, ending (in usd per share) $ 47.00 $ 36.43 $ 35.07
v3.25.0.1
Stock-Based Compensation - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details)
shares in Thousands
12 Months Ended
Dec. 31, 2024
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Exercise price range, lower range limit (in usd per share) $ 47.00
Exercise price range, upper range limit (in usd per share) $ 47.00
Options outstanding, number of options (in shares) | shares 12
Options outstanding, weighted average exercise price (in usd per share) $ 47.00
Options outstanding, weighted average remaining contractual life (in years) 2 months 12 days
v3.25.0.1
Stock-Based Compensation - Schedule of Restricted Stock, Market Stock Unit and Performance Stock Unit Activity (Details) - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Number of Shares        
Change in awards based on performance (in usd per share) $ 88.40      
Weighted Average Grant Date Fair Value        
Change in awards based on performance (in shares) 11      
Restricted Stock Units (RSUs)        
Number of Shares        
Nonvested, beginning (in shares) 3,596 2,944 1,620  
Granted (in shares) 1,513 1,981 2,186  
Vested (in shares) (1,231) (963) (609)  
Forfeited (in shares) (361) (366) (253)  
Nonvested, ending (in shares) 3,517 3,596 2,944  
Weighted Average Grant Date Fair Value        
Nonvested, beginning (in usd per share) $ 44.84 $ 44.96 $ 59.99 $ 90.75
Granted (in usd per share) 49.30 32.31 45.62  
Vested (in usd per share) 50.49 63.59 82.50  
Forfeited (in usd per share) 45.45 48.39 78.70  
Nonvested, ending (in usd per share) $ 44.84 $ 44.96 $ 59.99  
Market Stock Units and Performance Stock Units        
Number of Shares        
Nonvested, beginning (in shares) 934 399 281  
Granted (in shares) 389 587 239  
Vested (in shares) (82) (4) 0  
Forfeited (in shares) (191) (48) (121)  
Nonvested, ending (in shares) 1,061 934 399  
Weighted Average Grant Date Fair Value        
Nonvested, beginning (in usd per share) $ 49.58 $ 46.45 $ 57.42 $ 59.74
Granted (in usd per share) 59.92 39.59 46.75  
Vested (in usd per share) 45.90 23.21 0  
Forfeited (in usd per share) 59.12 55.55 41.71  
Nonvested, ending (in usd per share) $ 49.58 $ 46.45 $ 57.42  
v3.25.0.1
Stock-Based Compensation - Schedule of Monte Carlo Simulation For Market Stock Units Granted (Details) - TSR PSUs and MSUs
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility, minimum 53.50% 52.70%  
Volatility, maximum 54.10% 54.80%  
Volatility     45.40%
Risk-free interest rate, minimum 4.20% 3.90%  
Risk-free interest rate, maximum 4.50% 4.50%  
Risk-free interest rate     1.90%
Dividend yield 0.00% 0.00% 0.00%
Longest remaining performance period (in years) 3 years 3 years 3 years
v3.25.0.1
Stock-Based Compensation - Assumptions for Estimating the Fair Value of ESPP (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant date fair value per share (in usd per share) $ 28.10    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate, minimum 4.40% 5.30% 0.30%
Risk-free interest rate, maximum 5.40% 5.40% 4.70%
Expected life (in years) 6 months    
Expected volatility, minimum 38.40% 37.20% 49.70%
Expected volatility, maximum 40.80% 66.00% 65.60%
Dividend yield 0.00% 0.00% 0.00%
Employee Stock Purchase Plan | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life (in years)   6 months 3 months 18 days
Grant date fair value per share (in usd per share) $ 16.55 $ 9.71 $ 9.45
Employee Stock Purchase Plan | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life (in years)     6 months
Grant date fair value per share (in usd per share)   $ 9.87 $ 17.30
v3.25.0.1
Provision for Income Taxes - Schedule of U.S. and Non-U.S. Components of Loss Before Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income (Loss) Before Taxes [Line Items]      
Loss before income taxes $ (30,860) $ (61,822) $ (106,075)
U.S.      
Income (Loss) Before Taxes [Line Items]      
Loss before income taxes (38,615) (64,164)  
Non-U.S.      
Income (Loss) Before Taxes [Line Items]      
Loss before income taxes $ 7,755 $ 2,342  
v3.25.0.1
Provision for Income Taxes - Schedule of Components of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current taxes:      
Federal $ 0 $ 0 $ 0
Foreign 2,151 1,976 959
State 3,025 660 1,268
Total current taxes 5,176 2,636 2,227
Deferred taxes:      
Federal 1,427 420 420
Foreign 276 (251) (355)
State 797 757 616
Total deferred taxes 2,500 926 681
Provision for income taxes $ 7,676 $ 3,562 $ 2,908
v3.25.0.1
Provision for Income Taxes - Schedule of Significant Components of Deferred Taxes (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Deferred tax assets:    
NOL and credit carryforwards $ 116,084 $ 128,670
Deferred revenue 26,069 22,802
Accrued expenses and other 7,190 6,285
Stock-based compensation 11,080 11,425
Lease liabilities 11,633 13,600
Interest expense carryforwards 0 6,202
Convertible debt hedge 2,957 5,727
IRC Section 174 expenditures 73,860 56,711
Total deferred tax assets 248,873 251,422
Deferred tax liabilities:    
Deferred expenses (17,858) (14,960)
Depreciation and amortization (11,441) (17,491)
Capitalized software (1,690) (1,694)
Right of use assets (7,166) (8,497)
Total deferred tax liabilities (38,155) (42,642)
Deferred tax assets less tax liabilities 210,718 208,780
Less: valuation allowance (217,053) (212,614)
Net deferred tax liability $ (6,335) $ (3,834)
v3.25.0.1
Provision for Income Taxes - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Loss Carryforwards [Line Items]      
Net operating loss carryforwards $ 438,400,000 $ 504,000,000.0  
Net operating loss carryforwards subject to expiration 4,600,000 4,600,000  
Net operating loss carryforwards not subject to expiration 433,800,000 433,800,000  
Undistributed earnings of foreign subsidiaries 14,500,000    
Unrecognized tax benefits 1,096,000 720,000 $ 977,000
Unrecognized tax benefits that impact annual effective tax rate 1,100,000    
Unrecognized tax benefits, interest on income taxes accrued 0    
Continuing Operations      
Operating Loss Carryforwards [Line Items]      
Increase in valuation allowance 4,400,000    
Federal | Research Tax Credit Carryforward      
Operating Loss Carryforwards [Line Items]      
Tax credits 8,900,000 8,900,000  
State      
Operating Loss Carryforwards [Line Items]      
Tax credits $ 200,000 $ 300,000  
v3.25.0.1
Provision for Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]      
Income tax at U.S. statutory rate 21.00% 21.00% 21.00%
Increase in deferred tax valuation allowance (26.40%) (0.70%) (14.80%)
Stock compensation (0.20%) (12.40%) (4.80%)
Acquisitions 0.00% 0.00% (0.20%)
R&D credit 0.00% 0.00% (2.40%)
State taxes, net of federal benefit 1.30% 4.50% 0.60%
Change in uncertain tax positions (1.20%) 0.40% 1.50%
Executive compensation (13.50%) (4.80%) (1.80%)
GILTI inclusion (2.00%) 0.00% (1.60%)
Foreign NOL write-off 0.00% (14.50%) 0.00%
Federal return to provision 0.00% 2.70% 0.00%
Other permanent items (2.00%) (2.00%) (0.20%)
Income tax provision effective rate (23.10%) (5.80%) (2.70%)
v3.25.0.1
Provision for Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Unrecognized Tax Benefits [Roll Forward]    
Unrecognized tax benefits, beginning balance $ 720 $ 977
Gross increase related to prior year positions 38  
Gross decrease related to prior year positions   (510)
Gross increase related to current year positions 338 253
Unrecognized tax benefits, ending balance $ 1,096 $ 720
v3.25.0.1
Employee Benefit Plan (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Retirement Benefits [Abstract]      
Percentage match of employee contributions (in percent) 50.00%    
Percentage match of each participant's compensation (in percent) 6.00%    
Discretionary contribution $ 7.8 $ 7.8 $ 7.2
v3.25.0.1
Segments and Geographic Information (Details)
12 Months Ended
Dec. 31, 2024
segment
Segment Reporting [Abstract]  
Number of operating segments 1
v3.25.0.1
Related Parties (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Related Party Transaction [Line Items]      
Revenues $ 696,464 $ 624,624 $ 565,673
Related Party      
Related Party Transaction [Line Items]      
Revenues $ 0 $ 0 $ 0